image_name stringlengths 68 68 | type stringclasses 2
values | gt_table stringlengths 116 12.6k | table_fragment_1 stringlengths 43 8.42k | table_fragment_2 stringlengths 39 8.21k |
|---|---|---|---|---|
bb09f0784fc755a9896f064cc7a96b1c4c38226f7d5318cf56ffa2220c919e90.png | simple | <table><tr><td>Drug</td><td><i>n</i></td><td>Median Dosage (mg/kg/day)</td><td>Median Length of Treatment (Days)</td><td>Side Effects (<i>n</i>)</td></tr><tr><td>Rifampicin</td><td>415</td><td>17.5</td><td>240</td><td>Itch, vomit and headache (1); rash (1); hypertransaminasemia (4)</td></tr><tr><td>Pyrazinamide</td><td... | <table><tr><td>Drug</td><td>n</td><td>Median Dosage (mg/kg/day)</td><td>Median Length of Treatment (Days)</td></tr><tr><td>Rifampicin</td><td>415</td><td>17.5</td><td>240</td></tr><tr><td>Pyrazinamide</td><td>411</td><td>27</td><td>95</td></tr><tr><td>Isoniazid</td><td>396</td><td>10</td><td>242</td></tr><tr><td>Ethamb... | <table><tr><td>Side Effects (n)</td></tr><tr><td>Itch, vomit and headache (1); rash (1); hypertransaminasemia (4)</td></tr><tr><td>Hypertransaminasemia (7); vomit and malaise (1); epigastric pain (1); hyperuricemia (5); drug induced hepatitis (1)</td></tr><tr><td>Drug induced hepatitis (1); hypertransaminasemia (4)</td... |
9c7bb764e03f5ac14e09a1d01a80112f42f0677c6960b8058da23d4d9e1ffd31.png | simple | <table><tr><td>Genes group<sup>a</sup></td><td>Number of genes<sup>b</sup></td></tr><tr><td>Glucose-dependent</td><td>667 (18%)</td></tr><tr><td>Upregulated genes</td><td>349</td></tr><tr><td>Downregulated genes</td><td>318</td></tr><tr><td>CcpA-dependent</td><td>407 (11%)</td></tr><tr><td>Upregulated by CcpA</td><td>1... | <table><tr><td>Genes groupa</td><td>Number of genesb</td></tr><tr><td>Glucose-dependent</td><td>667 (18%)</td></tr><tr><td>Upregulated genes</td><td>349</td></tr><tr><td>Downregulated genes</td><td>318</td></tr><tr><td>CcpA-dependent</td><td>407 (11%)</td></tr><tr><td>Upregulated by CcpA</td><td>197</td></tr><tr><td>Do... | <table><tr><td>Genes groupa</td><td>Number of genesb</td></tr><tr><td>n a CcpA-dependent manner</td><td>61 (10%)</td></tr><tr><td>Upregulated genes</td><td>170</td></tr><tr><td>Downregulated genes</td><td>191</td></tr><tr><td>Regulated by glucose in a CcpA-independent manner</td><td>303 (8%)</td></tr><tr><td>Upregulate... |
98b5443f36da344ad0fea5f2887105ee6ad740279c61921d8783f885f4355c8a.png | complex | <table><tr><td>No.</td><td>Disease</td><td>Medicine</td><td>Formulation</td><td>Strength</td><td>Target size pack</td></tr><tr><td>1</td><td>Intestinal parasite</td><td>Albendazole</td><td>tablet</td><td>200 mg</td><td>2</td></tr><tr><td>2</td><td>Infectious disease</td><td>Amoxicillin</td><td>capsule</td><td>250 mg</t... | <table><tr><td>No.</td><td>Disease</td><td>Medicine</td><td>Formulation</td><td>Strength</td><td>Target size pack</td></tr><tr><td>1</td><td>Intestinal parasite</td><td>Albendazole</td><td>tablet</td><td>200 mg</td><td>2</td></tr><tr><td>2</td><td>Infectious disease</td><td>Amoxicillin</td><td>capsule</td><td>250 mg</t... | <table><tr><td>10</td><td>Infectious disease</td><td>Ceftriaxone</td><td>injection</td><td>500 mg vial</td><td>1 vial</td></tr><tr><td>11</td><td>Infectious disease</td><td>Chloramphenicol</td><td>tablet</td><td>250 mg</td><td>10</td></tr><tr><td></td><td>Infectious disease</td><td>Chloramphenicol</td><td>injection</td... |
ba6223a6c91e04c7f1658300e2be77451a043f3dbe167d8c5b43f8559b95aae5.png | simple | <table><tr><td>Gene Name</td><td>Forward primer sequence (5′-3′)</td><td>Reverse primer sequence (5′-3′)</td></tr><tr><td><i>β-actin</i></td><td>ACTGGGACGACATGGAGAAGATC</td><td>AAACCTTACCACTCCCGCC</td></tr><tr><td><i>ADRA1B</i></td><td>TCTGGTCGCTGTGCGTGAT</td><td>ATCAAGACCACCAAGACATCCG</td>... | <table><tr><td>Gene Name</td><td>Forward primer sequence (5′-3′)</td><td>Reverse primer sequence (5′-3′)</td></tr><tr><td>β-actin</td><td>ACTGGGACGACATGGAGAAGATC</td><td>AAACCTTACCACTCCCGCC</td></tr><tr><td>ADRA1B</td><td>TCTGGTCGCTGTGCGTGAT</td><td>ATCAAGACCACCAAGACATCCG</td></tr><tr><td>ARL3</td><td>CATCCCTTGCTCTACAT... | <table><tr><td>BAP1</td><td>ACCCGCACTCCTCCCTTAT</td><td>GAGAACCAAGTGGAGCAGACA</td></tr><tr><td>TRPA1</td><td>AGTAGCGGCAACATGTCCACC</td><td>CCAAACTAACCCTGAAAGACCG</td></tr></table> |
52403000bce10086232c4951f01e26346320bae007719794c6e3e93a130f5abc.png | simple | <table><tr><td>PPAR</td><td>Human</td><td>Mouse</td><td>Zebrafish</td></tr><tr><td>PPARA</td><td> </td><td> </td><td> </td></tr><tr><td> Genes</td><td>1</td><td>1</td><td>2</td></tr><tr><td> Splice variants</td><td>1</td><td>1</td><td>1 per gene</td></tr><tr><td> Isoforms</td><td>1</td><td>1</td><td>1 per gene</td></tr... | <table><tr><td>PPAR</td><td>Human</td><td>Mouse</td><td>Zebrafish</td></tr><tr><td>PPARA</td><td></td><td></td><td></td></tr><tr><td>Genes</td><td>1</td><td>1</td><td>2</td></tr><tr><td>Splice variants</td><td>1</td><td>1</td><td>1 per gene</td></tr><tr><td>Isoforms</td><td>1</td><td>1</td><td>1 per gene</td></tr><tr><... | <table><tr><td>PPARG</td><td></td><td></td><td></td></tr><tr><td>Genes</td><td>1</td><td>1</td><td>1</td></tr><tr><td>Splice variants</td><td>4</td><td>1</td><td>1</td></tr><tr><td>Isoforms</td><td>2</td><td>2</td><td>1</td></tr><tr><td>Size (cds, bp)</td><td>PPARG1 = 1,434PPARG2 = 1,518</td><td>PPARG1 = 1,428PPARG2 = ... |
325e411c6cb3ef4e4da81ced0baa3bf0cce9f1a33cd02d19da1f51aacc6470f1.png | complex | <table><tr><td></td><td colspan="2">SZ (<i>n</i> = 22)</td><td colspan="2">HC (<i>n</i> <i>=</i> 20)</td><td><i>t</i>/<i>x</i><sup>2</sup></td><td><i>p</i>-Value</td></tr><tr><td>Age, years</td><td colspan="2">33 (9.78)</td><td colspan="2">33.05 (9.31)</td><td>−0.002</td><td>0.99</td></tr><tr><td>Sex, M/F</td><td... | <table><tr><td></td><td colspan="2">SZ (n = 22)</td><td colspan="2">HC (n = 20)</td><td>t/x2</td><td>p-Value</td></tr><tr><td>Age, years</td><td colspan="2">33 (9.78)</td><td colspan="2">33.05 (9.31)</td><td>−0.002</td><td>0.99</td></tr><tr><td>Sex, M/F</td><td colspan="2">17/5</td><td colspan="2">14/6</td><td>0.63</td... | <table><tr><td colspan="7">Task reaction time, s</td></tr><tr><td>Congruent</td><td>0.91 (0.18)</td><td>0.90 (0.19)</td><td>0.80 (0.10)</td><td>0.79 (0.13)</td><td></td><td></td></tr><tr><td>Incongruent</td><td>1.04 (0.18)</td><td>1.03 (0.23)</td><td>1.00 (0.14)</td><td>0.91 (0.10)</td><td></td><td></td></tr><tr><td>St... |
e5612e9c6f68f49bccbccdda642f11abe33d3502a110c5ddb5d7c0137ad58bba.png | simple | <table><tr><td></td><td>Grade 2 (<i>n</i> = 20)</td><td>Grade 5 (<i>n</i> = 20)</td></tr><tr><td>Null-Prime</td><td>0.51 (0.50)</td><td>0.62 (0.49)</td></tr><tr><td>Prime</td><td>0.52 (0.50)</td><td>0.72 (0.45)</td></tr></table> | <table><tr><td></td><td>Grade 2 (n = 20)</td></tr><tr><td>Null-Prime</td><td>0.51 (0.50)</td></tr><tr><td>Prime</td><td>0.52 (0.50)</td></tr></table> | <table><tr><td>Grade 5 (n = 20)</td></tr><tr><td>0.62 (0.49)</td></tr><tr><td>0.72 (0.45)</td></tr></table> |
2899d25eae852c8a62005ae7cdfa2a39d4fa7d83162dbdb93799bfd8c04ab012.png | complex | <table><tr><td></td><td colspan="2">Pre-intervention</td><td colspan="2">Post-intervention</td><td></td></tr><tr><td></td><td>Intervention(n = 43)</td><td>Control(n = 30)</td><td>Intervention(n = 37)</td><td>Control(n = 28)</td><td>P-value</td></tr><tr><td colspan="4">Attitudes (agreement with statement)</td><td></td><... | <table><tr><td></td><td colspan="2">Pre-intervention</td><td colspan="2">Post-intervention</td><td></td></tr><tr><td></td><td>Intervention(n = 43)</td><td>Control(n = 30)</td><td>Intervention(n = 37)</td><td>Control(n = 28)</td><td>P-value</td></tr><tr><td colspan="4">Attitudes (agreement with statement)</td><td></td><... | <table><tr><td> as role models for being active</td><td>.0</td><td>.5</td><td>.0</td><td>5</td><td>.09</td></tr><tr><td>It is not the role of the teacher to teach movement skills</td><td>14.3</td><td>10.0</td><td>5.7</td><td>19.2</td><td>0.10</td></tr><tr><td>It is not important that children participate in structured ... |
3977e5b1af06798363e8c677deed730cd1906f196b94f0e0cf8314e9cb570dad.png | simple | <table><tr><td>Probe Set</td><td>z-score</td><td>DMFS</td><td>Gene Symbol</td><td>Gene Title</td></tr><tr><td>209648_x_at</td><td>4.01</td><td>-</td><td>SOCS5</td><td>suppressor of cytokine signaling 5</td></tr><tr><td>208127_s_at</td><td>3.75</td><td>-</td><td>SOCS5</td><td>suppressor of cytokine signaling 5</td></tr>... | <table><tr><td>Probe Set</td><td>z-score</td><td>DMFS</td><td>Gene Symbol</td><td>Gene Title</td></tr><tr><td>209648_x_at</td><td>4.01</td><td>-</td><td>SOCS5</td><td>suppressor of cytokine signaling 5</td></tr><tr><td>208127_s_at</td><td>3.75</td><td>-</td><td>SOCS5</td><td>suppressor of cytokine signaling 5</td></tr>... | <table><tr><td>213910_at</td><td>2.87</td><td>-</td><td>IGFBP7</td><td>insulin-like growth factor binding protein 7</td></tr><tr><td>212279_at</td><td>2.91</td><td>+</td><td>MAC30</td><td>hypothetical protein MAC30</td></tr><tr><td>213337_s_at</td><td>2.88</td><td>+</td><td>SOCS1</td><td>suppressor of cytokine signalin... |
91924dd56570848f679c975c94c205970ead0dc4210357b3af08c5009195cd5e.png | complex | <table><tr><td rowspan="2" colspan="2"> </td><td colspan="2">Blood culture/IFAT</td><td rowspan="2">Total</td></tr><tr><td>Positive</td><td>Negative</td></tr><tr><td rowspan="2">PCR</td><td>Positive</td><td>25/29</td><td>11/7</td><td>36/36</td></tr><tr><td>Negative</td><td>4/3</td><td>10/11</td><td>14/14</td></tr><tr><... | <table><tr><td rowspan="2" colspan="2"></td></tr><tr></tr><tr><td rowspan="2">PCR</td><td>Positive</td></tr><tr><td>Negative</td></tr><tr><td></td><td>Total</td></tr></table> | <table><tr><td colspan="2">Blood culture/IFAT</td><td rowspan="2">Total</td></tr><tr><td>Positive</td><td>Negative</td></tr><tr><td>25/29</td><td>11/7</td><td>36/36</td></tr><tr><td>4/3</td><td>10/11</td><td>14/14</td></tr><tr><td>29/32</td><td>21/18</td><td>50/50</td></tr></table> |
d70c49ec6bdbc35993c1a5ae5a609d42e4809c1b0b3326ed9512a12d5d8bc0b3.png | simple | <table><tr><td></td><td>Control group</td><td>Study group</td><td>Total analysed</td></tr><tr><td>Toes</td><td>156 (50 %)</td><td>156 (50 %)</td><td>312</td></tr><tr><td> Males</td><td>37</td><td>26</td><td>63</td></tr><tr><td> Females</td><td>44</td><td>58</td><td>102</td></tr><tr><td>Average age</td><td>27.19</td><td... | <table><tr><td></td><td>Control group</td><td>Study group</td><td>Total analysed</td></tr><tr><td>Toes</td><td>156 (50 %)</td><td>156 (50 %)</td><td>312</td></tr><tr><td>Males</td><td>37</td><td>26</td><td>63</td></tr><tr><td>Females</td><td>44</td><td>58</td><td>102</td></tr><tr><td>Average age</td><td>27.19</td><td>2... | <table><tr><td>Standard deviation</td><td>9.48</td><td>9.04</td><td>9.26</td></tr><tr><td>Median (range)</td><td>23 (12–50)</td><td>23 (10–50)</td><td>23 (10–50)</td></tr></table> |
ad63902c096ecfb0fc8dd121fa3dd5aa90212d6a3c3a49059e8a358fd3e5a782.png | simple | <table><tr><td>Variable</td><td>Description and unit</td><td>Mean</td><td>Std. Dev.</td></tr><tr><td>Hypertension</td><td>1if has hypertension; 0 otherwise</td><td>0.43</td><td>0.49</td></tr><tr><td>Obesity</td><td>1 if obese; 0 otherwise</td><td>0.31</td><td>0.46</td></tr><tr><td>Age</td><td>In years</td><td>55.46</td... | <table><tr><td>Variable</td><td>Description and unit</td><td>Mean</td><td>Std. Dev.</td></tr><tr><td>Hypertension</td><td>1if has hypertension; 0 otherwise</td><td>0.43</td><td>0.49</td></tr><tr><td>Obesity</td><td>1 if obese; 0 otherwise</td><td>0.31</td><td>0.46</td></tr><tr><td>Age</td><td>In years</td><td>55.46</td... | <table><tr><td>Variable</td><td>Description and unit</td><td>Mean</td><td>Std. Dev.</td></tr><tr><td>Income</td><td>Annual income in dollars</td><td>$40,774</td><td>$24,815</td></tr><tr><td>Gender</td><td>1 if male; 0 if female</td><td>0.38</td><td>0.48</td></tr><tr><td>Race</td><td>1 if white; 0 if race other than whi... |
2e4b8bd519effff338f6d686f27331d736a7a8ede4d67acca1bbdd778a218460.png | simple | <table><tr><td>References</td><td>Primary outcomes</td><td>Secondary outcomes</td></tr><tr><td>Fiske (strong)<sup>1</sup>[17]</td><td>There was no difference in sales of healthier food options between intervention and control groups.</td><td></td></tr><tr><td>Kocken (strong) [20]</td><td>Higher sales of healthier food ... | <table><tr><td>References</td><td>Primary outcomes</td><td>Secondary outcomes</td></tr></table> | <table><tr><td>Fiske (strong)1[17]</td><td>There was no difference in sales of healthier food options between intervention and control groups.</td><td></td></tr><tr><td>Kocken (strong) [20]</td><td>Higher sales of healthier food options were observed in intervention groups compared to control groups.</td><td></td></tr>... |
c5c18a71e43d11fa5600c7acd7db4f1ddb974d3a2098d96fb6367c289e6fd824.png | simple | <table><tr><td>Section of economizer</td><td>Condition design</td></tr><tr><td></td><td>Length was 250 mm</td></tr><tr><td>Evaporator section</td><td>Hot water flow was 80°C</td></tr><tr><td></td><td>Volumetric flow rate was 5 l/min</td></tr><tr><td>Adiabatic section</td><td>Length was 250 mm</td></tr><tr><td></td... | <table><tr><td>Section of economizer</td><td>Condition design</td></tr><tr><td></td><td>Length was 250 mm</td></tr></table> | <table><tr><td>Section of economizer</td><td>Condition design</td></tr><tr><td>Evaporator section</td><td>Hot water flow was 80°C</td></tr><tr><td></td><td>Volumetric flow rate was 5 l/min</td></tr><tr><td>Adiabatic section</td><td>Length was 250 mm</td></tr><tr><td></td><td>Length was 250 mm</td></tr><tr><td>Condenser... |
6bf53173b9992fe30bc678f4cf643926d09bce52abfeb1b083f9bc3f24a50507.png | simple | <table><tr><td>Item</td><td>Dimension</td><td>Missing values (%)</td></tr><tr><td>1. I work hard to keep my HIV a secret<sup>a</sup></td><td>Disclosure concerns</td><td>0.0</td></tr><tr><td>2. Most people believe a person who has HIV is dirty<sup>a</sup></td><td>Public attitudes</td><td>3.4</td></tr><tr><td>3. Having H... | <table><tr><td>Item</td></tr><tr><td>1. I work hard to keep my HIV a secreta</td></tr><tr><td>2. Most people believe a person who has HIV is dirtya</td></tr><tr><td>3. Having HIV makes me feel uncleana</td></tr><tr><td>4. Most people think a person with HIV is disgustinga</td></tr><tr><td>5. Having HIV makes me feel I'... | <table><tr><td>Dimension</td><td>Missing values (%)</td></tr><tr><td>Disclosure concerns</td><td>0.0</td></tr><tr><td>Public attitudes</td><td>3.4</td></tr><tr><td>Negative self-image</td><td>8.6</td></tr><tr><td>Public attitudes</td><td>1.7</td></tr><tr><td>Negative self-image</td><td>0.0</td></tr><tr><td>Public attit... |
a21a52f93f722a2b72809159ae10450c72e7a2b7809fd762ee21598613ff08df.png | complex | <table><tr><td></td><td colspan="2">Healthy normal control</td><td colspan="2">Obese control</td><td colspan="2">OHS</td><td colspan="2">OSAS</td><td>P</td></tr><tr><td></td><td>Med.</td><td>Perc.25/75</td><td>Med.</td><td>Perc.25/75</td><td>Med.</td><td>Perc.25/75</td><td>Med.</td><td>Perc.25/75</td><td></td></tr><tr>... | <table><tr><td></td><td colspan="2">Healthy normal control</td><td colspan="2">Obese control</td><td colspan="2">OHS</td><td colspan="2">OSAS</td><td>P</td></tr><tr><td></td><td>Med.</td><td>Perc.25/75</td><td>Med.</td><td>Perc.25/75</td><td>Med.</td><td>Perc.25/75</td><td>Med.</td><td>Perc.25/75</td><td></td></tr><tr>... | <table><tr><td>Total number of correct answers</td><td>76</td><td>6388.25</td><td>78</td><td>62.584.5</td><td>56</td><td>43.578.5</td><td>66</td><td>52.572.5</td><td>0.12</td></tr><tr><td>Total number of incorrect answers</td><td>23.5</td><td>12.7537.25</td><td>32</td><td>24.564</td><td>72</td><td>49.584.5</td><td>62</... |
04d3fec20d4d20d9ce2fba59093be99545c0de8aebea23cd43de87dc6e1267f2.png | complex | <table><tr><td>Variable</td><td><35</td><td>p-value</td><td>≥35</td><td>p-value</td></tr><tr><td> </td><td>Adjusted odds ratio (95% CI)</td><td> </td><td>Adjusted odds ratio (95% CI)</td><td> </td></tr><tr><td colspan="5">a. Adjusted Confounder Model for not having tested for HIV in the past 2 years, stratifie... | <table><tr><td>Variable</td><td><35</td><td>p-value</td><td>≥35</td><td>p-value</td></tr><tr><td></td><td>Adjusted odds ratio (95% CI)</td><td></td><td>Adjusted odds ratio (95% CI)</td><td></td></tr><tr><td colspan="5">a. Adjusted Confounder Model for not having tested for HIV in the past 2 years, stratified by age</td... | <table><tr><td>Variable</td><td><35</td><td>p-value</td><td>≥35</td><td>p-value</td></tr><tr><td></td><td>Adjusted odds ratio (95% CI)</td><td></td><td>Adjusted odds ratio (95% CI)</td><td></td></tr><tr><td>Asian ethnicity</td><td>2.04 (1.08-3.86)</td><td>0.028</td><td>0.65 (0.28-1.51)</td><td>0.32</td></tr><tr><td>Eng... |
066dadc6ba9c3a7b82ff3f33d888610fa58a8a6f17228240457b11e2013baa28.png | complex | <table><tr><td rowspan="2">Variables</td><td rowspan="2">Category</td><td>(1)</td><td>(2)</td><td>(3)</td><td>(4)</td><td>(5)</td></tr><tr><td>rifEI</td><td>rifWI</td><td>rifARCI</td><td>rifSRCI</td><td>rifAC</td></tr><tr><td colspan="7"><i>Demographic characteristics</i></td></tr><tr><td rowspan="2">Gender</td><td>Fem... | <table><tr><td rowspan="2">Variables</td><td rowspan="2">Category</td><td>(1)</td></tr><tr><td>rifEI</td></tr><tr><td colspan="3">Demographic characteristics</td></tr><tr><td rowspan="2">Gender</td><td>Female (Reference)</td><td></td></tr><tr><td>Male</td><td>−0.019***</td></tr><tr><td rowspan="4">Age group</td><td>Qua... | <table><tr><td>(2)</td><td>(3)</td><td>(4)</td><td>(5)</td></tr><tr><td>rifWI</td><td>rifARCI</td><td>rifSRCI</td><td>rifAC</td></tr><tr><td colspan="4">Demographic characteristics</td></tr><tr><td></td><td></td><td></td><td></td></tr><tr><td>−0.019***</td><td>−0.011***</td><td>−0.008**</td><td>−0.005***</td></tr><tr><... |
504c5c728e949ca8293489abf3feb2020c4bb5e755aa67d5cb8a4cfb5ca65950.png | complex | <table><tr><td rowspan="2" colspan="2"><i>Variable</i></td><td colspan="2"><i>Cross River</i></td><td colspan="2"><i>Bauchi</i></td></tr><tr><td><i>n/N</i></td><td><i>OR (95% CIca)</i></td><td><i>n/N</i></td><td><i>OR (95% CIca)</i></td></tr><tr><td rowspan="2"><i>Sex of child</i></td><td>Male</td><td>767/2,206</td><td... | <table><tr><td colspan="2">Variable</td><td colspan="2">Cross River</td><td colspan="2">Bauchi</td></tr></table> | <table><tr><td colspan="2">Variable</td><td>n/N</td><td>OR (95% CIca)</td><td>n/N</td><td>OR (95% CIca)</td></tr><tr><td rowspan="2">Sex of child</td><td>Male</td><td>767/2,206</td><td>1.04</td><td>1,191/2,590</td><td>1.02</td></tr><tr><td>Female</td><td>769/2,276</td><td>(0.92–1.18)</td><td>1,112/2,448</td><td>(0.92–1... |
e8f65ade0fe45e659f23134787a7d2d949b0791e133768d6430bcfd469512cca.png | complex | <table><tr><td rowspan="2">Anatomic site</td><td rowspan="2">Time period</td><td colspan="3">Incidence rate (95% CI) by race/ethnicity</td><td colspan="2">Rate ratios (95% CI)</td></tr><tr><td>Non-Hispanic white </td><td>Hispanic</td><td>American Indian</td><td>H versus NHW</td><td>AI versus NHW</td></tr><tr><td colspa... | <table><tr><td rowspan="2">Anatomic site</td><td rowspan="2">Time period</td><td colspan="3">Incidence rate (95% CI) by race/ethnicity</td><td colspan="2">Rate ratios (95% CI)</td></tr><tr><td>Non-Hispanic white</td><td>Hispanic</td><td>American Indian</td><td>H versus NHW</td><td>AI versus NHW</td></tr><tr><td colspan... | <table><tr><td rowspan="2">Anatomic site</td><td rowspan="2">Time period</td><td colspan="3">Incidence rate (95% CI) by race/ethnicity</td><td colspan="2">Rate ratios (95% CI)</td></tr><tr><td>Non-Hispanic white</td><td>Hispanic</td><td>American Indian</td><td>H versus NHW</td><td>AI versus NHW</td></tr><tr><td rowspan... |
107c07bf78403bef6392dea2ed1f8e1a39baeb6b2e5cf345c6f291910c5e42c8.png | complex | <table><tr><td rowspan="2">Characteristics</td><td colspan="3">Lipoatrophy</td><td colspan="3">Fat abnormality</td></tr><tr><td>OR</td><td>95% CI</td><td><i>P</i> value</td><td>OR</td><td>95% CI</td><td><i>P</i> value</td></tr><tr><td>Boys</td><td>4.3</td><td>1.6–11.6</td><td>0.004</td><td>2.7</td><td>1.2–6... | <table><tr><td rowspan="2">Characteristics</td><td colspan="3">Lipoatrophy</td><td colspan="3">Fat abnormality</td></tr><tr><td>OR</td><td>95% CI</td><td>P value</td><td>OR</td><td>95% CI</td><td>P value</td></tr><tr><td>Boys</td><td>4.3</td><td>1.6–11.6</td><td>0.004</td><td>2.7</td><td>1.2–6.3</td><td>0.02</td></tr><... | <table><tr><td>≥3 years vs No</td><td>2.2</td><td>0.9–5.4</td><td>0.09</td><td>1.8</td><td>0.7–4.3</td><td>0.21</td></tr></table> |
2b703fac727a40d26eec86828ad1f5c7c650a465b20c16ed1172a642efb2bcfa.png | simple | <table><tr><td></td><td>Aboriginal</td><td>Non-Aboriginal</td><td></td></tr><tr><td></td><td>Had surgery n/N (%)</td><td>Had surgery n/N (%)</td><td><i>p</i>-value<sup>b</sup></td></tr><tr><td>All people</td><td>37/120 (30)</td><td>2666/6757 (39)</td><td>-</td></tr><tr><td>Sex</td><td></td><td></td><td>0.972</td></tr><... | <table><tr><td></td><td>Aboriginal</td><td>Non-Aboriginal</td><td></td></tr><tr><td></td><td>Had surgery n/N (%)</td><td>Had surgery n/N (%)</td><td>p-valueb</td></tr><tr><td>All people</td><td>37/120 (30)</td><td>2666/6757 (39)</td><td>-</td></tr><tr><td>Sex</td><td></td><td></td><td>0.972</td></tr><tr><td>Male</td><t... | <table><tr><td></td><td>Aboriginal</td><td>Non-Aboriginal</td><td></td></tr><tr><td></td><td>Had surgery n/N (%)</td><td>Had surgery n/N (%)</td><td>p-valueb</td></tr><tr><td>Comorbiditiesd</td><td></td><td></td><td>0.018</td></tr><tr><td>No comorbidities</td><td>9/41 (22)</td><td>1390/3196 (43)</td><td></td></tr><tr><... |
f495ad6bcd261837643733db09b210b8302080194871ab71acaba0617b5f1f78.png | complex | <table><tr><td>Variable</td><td colspan="3">Training groups</td><td>P value‡</td></tr><tr><td></td><td>Control group<i>n </i>= 60Mean (SD)</td><td>Endurance <i>n </i>= 59Mean (SD)</td><td>Strength <i>n </i>= 60Mean (SD)</td><td></td></tr><tr><td>Demographic</td><td></td><td></td><td></td><td></td></tr><tr><td> Ag... | <table><tr><td>Variable</td><td colspan="3">Training groups</td></tr><tr><td></td><td>Control groupn = 60Mean (SD)</td><td>Endurance n = 59Mean (SD)</td><td>Strength n = 60Mean (SD)</td></tr><tr><td>Demographic</td><td></td><td></td><td></td></tr><tr><td>Age, years</td><td>46 (5)</td><td>46 (6)</td><td>45 (6)</td></tr>... | <table><tr><td>P value‡</td></tr><tr><td></td></tr><tr><td></td></tr><tr><td>0.73</td></tr><tr><td>0.74</td></tr><tr><td>0.64</td></tr><tr><td>0.40</td></tr><tr><td></td></tr><tr><td>0.30</td></tr><tr><td>0.89</td></tr></table> |
436b5f6229fa146a8bbcec5fd2f739dfe88c159bd24cee86e179e7165f3c9aa4.png | simple | <table><tr><td>Detection range</td><td>Passerinesa</td><td>Wadersb</td><td>Hooded crow (<i>Corvus cornix</i>)</td><td>Gulls</td><td>Mallard (<i>Anas platyrhynchos</i>)</td><td>Raven (<i>Corvus corax</i>)</td><td>Greylag goose (<i>Anser anser</i>)</td><td>White‐tailed eagle (<i>Haliaeetus albicilla</i>)</td></tr><... | <table><tr><td>Detection range</td><td>Passerinesa</td><td>Wadersb</td><td>Hooded crow (Corvus cornix)</td><td>Gulls</td><td>Mallard (Anas platyrhynchos)</td><td>Raven (Corvus corax)</td><td>Greylag goose (Anser anser)</td><td>White‐tailed eagle (Haliaeetus albicilla)</td></tr><tr><td>RCS (dBm2)</td><td>−32.0</td><td>−... | <table><tr><td>Detection range</td><td>Passerinesa</td><td>Wadersb</td><td>Hooded crow (Corvus cornix)</td><td>Gulls</td><td>Mallard (Anas platyrhynchos)</td><td>Raven (Corvus corax)</td><td>Greylag goose (Anser anser)</td><td>White‐tailed eagle (Haliaeetus albicilla)</td></tr><tr><td>Maximum</td><td>2,866</td><td>4,37... |
6c5c266c4fa7cd9dbf25e9905a1044168e71c3642a55de702491a3928f5d30d3.png | simple | <table><tr><td></td><td><i>mean (SD)</i></td></tr><tr><td>Age, y</td><td>31.6 (4.3)</td></tr><tr><td>Age at menarche, y</td><td>13.2 (1.5)</td></tr><tr><td>Pre-pregnancy BMI, kg/m<sup>2</sup></td><td>24.3 (3.7)</td></tr><tr><td></td><td><i>% (n)</i></td></tr><tr><td>Pre-pregnancy BMI group</td><td></td></tr><tr><td> <i... | <table><tr><td></td><td>mean (SD)</td></tr><tr><td>Age, y</td><td>31.6 (4.3)</td></tr><tr><td>Age at menarche, y</td><td>13.2 (1.5)</td></tr><tr><td>Pre-pregnancy BMI, kg/m2</td><td>24.3 (3.7)</td></tr><tr><td></td><td>% (n)</td></tr><tr><td>Pre-pregnancy BMI group</td><td></td></tr><tr><td>Underweight (BMI < 18.5)</td... | <table><tr><td></td><td>mean (SD)</td></tr><tr><td>Completed post high school education</td><td>68 (80)</td></tr></table> |
8d32758f2211610bd131a8f02069dbf7a9be911357a1813f73bc7b16f5afd311.png | complex | <table><tr><td>Shot ID</td><td colspan="2">Dimensions</td><td>Treatment</td><td colspan="2">No. of samples analysed</td></tr><tr><td> </td><td><i>d</i> [mm]</td><td>Weight [g]</td><td> </td><td>C</td><td>S</td></tr><tr><td>81A1527</td><td>85.0</td><td>2410.8</td><td>SS</td><td>2</td><td>0</td></tr><tr><td>81A2310</td><... | <table><tr><td>Shot ID</td><td colspan="2">Dimensions</td><td>Treatment</td><td colspan="2">No. of samples analysed</td></tr><tr><td></td><td>d [mm]</td><td>Weight [g]</td><td></td><td>C</td><td>S</td></tr></table> | <table><tr><td>81A1527</td><td>85.0</td><td>2410.8</td><td>SS</td><td>2</td><td>0</td></tr><tr><td>81A2310</td><td>82.6</td><td>2199.9</td><td>SS</td><td>2</td><td>0</td></tr><tr><td>81A3470</td><td>84.8</td><td>2107.0</td><td>SS</td><td>2</td><td>0</td></tr><tr><td>81A3550</td><td>84.1</td><td>2361.0</td><td>SS</td><t... |
960ef108f9cda8b49229af8c961135f98cf2fcfff6490db7fd9a1510f429baf7.png | complex | <table><tr><td></td><td colspan="2">A</td><td colspan="2">B</td><td colspan="2">C</td><td colspan="2">D</td><td colspan="2">E</td><td colspan="2">F</td></tr><tr><td>Subject J \Cells</td><td>WT</td><td>MT</td><td>WT</td><td>MT</td><td>WT</td><td>MT</td><td>WT</td><td>MT</td><td>WT</td><td>MT</td><td>WT</td><td>MT</td></... | <table><tr><td></td><td colspan="2">A</td><td colspan="2">B</td><td colspan="2">C</td><td>D</td></tr><tr><td>Subject J \Cells</td><td>WT</td><td>MT</td><td>WT</td><td>MT</td><td>WT</td><td>MT</td><td>WT</td></tr><tr><td>1-1</td><td>3</td><td>6</td><td>3</td><td>3</td><td>3</td><td>3</td><td>6</td></tr><tr><td>1-2</td><... | <table><tr><td>D</td><td colspan="2">E</td><td colspan="2">F</td></tr><tr><td>MT</td><td>WT</td><td>MT</td><td>WT</td><td>MT</td></tr><tr><td>9</td><td>11</td><td>7</td><td>1</td><td>4</td></tr><tr><td>8</td><td>4</td><td>7</td><td>2</td><td>6</td></tr><tr><td>2</td><td>0</td><td>2</td><td>1</td><td>1</td></tr><tr><td>... |
972d8627912815cf19076f04f2f28beb744fcff4acb5014ad783a8c856c2b446.png | simple | <table><tr><td></td><td></td><td>Status at consent</td><td></td><td></td></tr><tr><td></td><td></td><td>High non-tryer</td><td>High tryer</td><td>Pregnant</td></tr><tr><td></td><td></td><td>%</td><td>%</td><td>%</td></tr><tr><td>Age, years</td><td><18</td><td>0</td><td>0</td><td>1.4</td></tr><tr><td></td><td>18̵... | <table><tr><td></td><td></td><td>Status at consent</td></tr><tr><td></td><td></td><td>High non-tryer</td></tr><tr><td></td><td></td><td>%</td></tr><tr><td>Age, years</td><td><18</td><td>0</td></tr><tr><td></td><td>18–19</td><td>*</td></tr><tr><td></td><td>20–34</td><td>90.9</td></tr><tr><td></td><td>35+</td><td>*</td><... | <table><tr><td></td><td></td></tr><tr><td>High tryer</td><td>Pregnant</td></tr><tr><td>%</td><td>%</td></tr><tr><td>0</td><td>1.4</td></tr><tr><td>0</td><td>3.3</td></tr><tr><td>83.7</td><td>76.5</td></tr><tr><td>16.3</td><td>18.7</td></tr><tr><td>30.7 (4.1)</td><td>29.2 (5.7)</td></tr><tr><td>*</td><td>4.2</td></tr><t... |
38bf9122af53bf20a006560d02bb03d751006a60d5cd6b97ab0843837932eb66.png | simple | <table><tr><td>Organism</td><td>Degradosome-dependence</td><td>PNPase role</td><td>References</td></tr><tr><td><i>Yersinia pestis</i></td><td>?</td><td>Catalytic activity plays an essential role in cold growth</td><td>Rosenzweig et al., 2005</td></tr><tr><td></td><td>?</td><td>Required for virulence in a catalytic-acti... | <table><tr><td>Organism</td><td>Degradosome-dependence</td><td>PNPase role</td><td>References</td></tr><tr><td>Yersinia pestis</td><td>?</td><td>Catalytic activity plays an essential role in cold growth</td><td>Rosenzweig et al., 2005</td></tr><tr><td></td><td>?</td><td>Required for virulence in a catalytic-activity-in... | <table><tr><td>Yersinia pseudotuberculosis</td><td>No</td><td>S1 and KH domains also contribute to cold growth.</td><td>Rosenzweig et al., 2005</td></tr><tr><td></td><td>No</td><td>Degradosome-independent role in cold growth</td><td>Henry et al., 2012</td></tr><tr><td></td><td>Yes</td><td>Degradosome assembly required ... |
18fff567e3d450cf677940bacfde405b65c115d0468ee3319fbdbfe2481abc20.png | simple | <table><tr><td>Number</td><td>Outcomes</td></tr><tr><td>1</td><td>Patient-provider communication</td></tr><tr><td>2</td><td>Monitor treatment response</td></tr><tr><td>3</td><td>Detect unrecognised problems</td></tr><tr><td>4</td><td>Changes to patient health behaviour</td></tr><tr><td>5</td><td>Changes to patient mana... | <table><tr><td>Number</td></tr><tr><td>1</td></tr><tr><td>2</td></tr><tr><td>3</td></tr><tr><td>4</td></tr><tr><td>5</td></tr><tr><td>6</td></tr><tr><td>7</td></tr><tr><td>8</td></tr><tr><td>9</td></tr><tr><td>10</td></tr><tr><td>11</td></tr><tr><td>12</td></tr></table> | <table><tr><td>Outcomes</td></tr><tr><td>Patient-provider communication</td></tr><tr><td>Monitor treatment response</td></tr><tr><td>Detect unrecognised problems</td></tr><tr><td>Changes to patient health behaviour</td></tr><tr><td>Changes to patient management</td></tr><tr><td>Improved patient satisfaction</td></tr><t... |
21ae9618cef61888dc41b035e19c6b7f164edf8409f0ba03add911f4413bf7b1.png | complex | <table><tr><td>Stratification criteria</td><td>Description</td></tr><tr><td rowspan="6">Physician Integrated Network (PIN) [30]</td><td>A Manitoba Health primary care renewal initiative that focuses on fee-for-service (FFS) physician groups.</td></tr><tr><td>Its goal is to facilitate systemic improvements in the delive... | <table><tr><td>Stratification criteria</td><td>Description</td></tr><tr><td rowspan="4">Physician Inte</td><td>A Manitoba Health primary care renewal initiative that focuses on fee-for-service (FFS) physician groups.</td></tr><tr><td>Its goal is to facilitate systemic improvements in the delivery of primary care.</td><... | <table><tr><td>Stratification criteria</td><td>Description</td></tr><tr><td rowspan="3">grated Network (PIN) [30]</td><td> improve access to primary care</td></tr><tr><td>● To improve Primary Care Providers’ access to and use of information</td></tr><tr><td>● To improve the work life for all primary care providers</td>... |
6eaeb39b9bf455e7f6db849912ef2bf479de22285ece646d283f1dbc1c499a34.png | complex | <table><tr><td>Tissue sample</td><td>Type of core</td><td>No. of cores in TMA blocks</td></tr><tr><td>Control Normal Samples</td><td>Normal</td><td>119</td></tr><tr><td rowspan="2">DCIS</td><td>Normal in DCIS</td><td>12</td></tr><tr><td>DCIS pure lesion</td><td>54</td></tr><tr><td rowspan="3">IDC</td><td>Normal in IDC<... | <table><tr><td>Tissue sample</td><td>Type of core</td><td>No. of cores in TMA blocks</td></tr><tr><td>Control Normal Samples</td><td>Normal</td><td>119</td></tr><tr><td>DCIS</td><td>Normal in DCIS</td><td>12</td></tr></table> | <table><tr><td>DCIS</td><td>DCIS pure lesion</td><td>54</td></tr><tr><td rowspan="3">IDC</td><td>Normal in IDC</td><td>61</td></tr><tr><td>DCIS in IDC</td><td>39</td></tr><tr><td>IDC pure lesion</td><td>120</td></tr></table> |
bc8c9b6a31e0f2ff83578a0fa82aafceccc5047313b80739452feef7e665abda.png | complex | <table><tr><td rowspan="2">Cancer</td><td rowspan="2">Accession number</td><td rowspan="2">Array</td><td colspan="2">Sample size</td><td colspan="2">Log-2 mRNA signal intensity (mean ± SD*)</td><td rowspan="2"><i>P</i></td></tr><tr><td>Control</td><td>Case</td><td>Control</td><td>Case</td></tr><tr><td rowspan="2">... | <table><tr><td rowspan="2">Cancer</td><td rowspan="2">Accession number</td></tr><tr></tr><tr><td rowspan="2">Breast cancer</td><td>GSE42568</td></tr><tr><td>GSE15852</td></tr><tr><td rowspan="2">Lung cancer</td><td>E-MEXP-231</td></tr><tr><td>GSE19804</td></tr><tr><td rowspan="2">Prostate cancer</td><td>GSE6956</td></t... | <table><tr><td rowspan="2">Array</td><td colspan="2">Sample size</td><td colspan="2">Log-2 mRNA signal intensity (mean ± SD*)</td><td rowspan="2">P</td></tr><tr><td>Control</td><td>Case</td><td>Control</td><td>Case</td></tr><tr><td>HG-U133_Plus_2</td><td>17</td><td>104</td><td>6.36 ± 0.54</td><td>7.57 ± 0.78</td><td><0... |
1fd07f9865a91ca5d46b878060750d58446db314080c97ceb2bb6165f492f3e3.png | simple | <table><tr><td> </td><td><i>Dry mucus membranes (eyes/mouth)</i></td><td><i>Lighter/uneasy sleep</i></td><td><i>Heavier sleep</i></td><td><i>Sleepiness at daytime</i></td><td><i>Increased fatigue</i></td><td><i>Dizziness</i></td></tr><tr><td>Patient #1</td><td>x</td><td>x</td><td> </td><td> </td><td>x</td><td> </td></t... | <table><tr><td></td><td>Dry mucus membranes (eyes/mouth)</td><td>Lighter/uneasy sleep</td><td>Heavier sleep</td><td>Sleepiness at daytime</td><td>Increased fatigue</td></tr><tr><td>Patient #1</td><td>x</td><td>x</td><td></td><td></td><td>x</td></tr><tr><td>Patient #2</td><td>x</td><td></td><td></td><td>x</td><td></td><... | <table><tr><td>Dizziness</td></tr><tr><td></td></tr><tr><td></td></tr><tr><td></td></tr><tr><td>x</td></tr><tr><td></td></tr></table> |
72e136a0794981acb6d01322ded5f7a5d5e3897398c70f274b269dc42614b169.png | simple | <table><tr><td></td><td>Surgery group</td><td>Packing group</td><td>P</td></tr><tr><td>Re-bleeding</td><td>0</td><td>4</td><td>0.001</td></tr><tr><td>Discomfort after the treatment</td><td>2.4±1.4</td><td>7.6±1.0</td><td>0.001</td></tr><tr><td>Adhesion of nasal cavity</td><td>2</td><td>7</td><td>0.007</td></t... | <table><tr><td></td><td>Surgery group</td><td>Packing group</td><td>P</td></tr></table> | <table><tr><td>Re-bleeding</td><td>0</td><td>4</td><td>0.001</td></tr><tr><td>Discomfort after the treatment</td><td>2.4±1.4</td><td>7.6±1.0</td><td>0.001</td></tr><tr><td>Adhesion of nasal cavity</td><td>2</td><td>7</td><td>0.007</td></tr></table> |
c52768e689163dada01245da72d345116567f77ff3cca4449e421979b550d86e.png | complex | <table><tr><td colspan="2">Gene</td><td>Primer sequences</td></tr><tr><td rowspan="3">hsa-miR-155</td><td>RT</td><td>5′-GCGCGTGAGCAGGCTGGAGAAATTAACCACGCGCACCCCT-3′</td></tr><tr><td>Forward</td><td>5′- CTTAATGCTAATCGTGAT -3′</td></tr><tr><td>Reverse</td><td>5′- GAG CAG GCT GGA GAA -3′... | <table><tr><td colspan="2">Gene</td><td>Primer sequences</td></tr><tr><td>hsa-miR-155</td><td>RT</td><td>5′-GCGCGTGAGCAGGCTGGAGAAATTAACCACGCGCACCCCT-3′</td></tr></table> | <table><tr><td rowspan="2">hsa-miR-155</td><td>Forward</td><td>5′- CTTAATGCTAATCGTGAT -3′</td></tr><tr><td>Reverse</td><td>5′- GAG CAG GCT GGA GAA -3′</td></tr><tr><td rowspan="3">hsa-miR-146a</td><td>RT</td><td>5′-GCGCGTGAGCAGGCTGGAGAAATTAACCACGCGCAACCCA -3′</td></tr><tr><td>Forward</td><td>5′- CTGAGAACTGAATTCCA -3′</... |
a6f0d33a854b7bef8be5fdbfee9fe42451754a09b6ab2895243a57063e7e31b5.png | simple | <table><tr><td>Division</td><td>Asembo</td><td>Uyoma</td><td>Maranda</td><td>Nyang’oma</td><td>Usigu</td><td>Overall</td></tr><tr><td>Mean [F]±SD</td><td>0.92±0.46</td><td>1.39±0.84</td><td>0.69±0.42</td><td>1.00±0.59</td><td>0.78±0.66</td><td>0.85±0.67</td></tr><tr><td>Highest<... | <table><tr><td>Division</td><td>Asembo</td><td>Uyoma</td><td>Maranda</td></tr><tr><td>Mean [F]±SD</td><td>0.92±0.46</td><td>1.39±0.84</td><td>0.69±0.42</td></tr><tr><td>Highest</td><td>2.27</td><td>5.44</td><td>1.7</td></tr><tr><td>>3.0 ppm</td><td>-</td><td>01(9.1%)</td><td>-</td></tr><tr><td>1.5-2.9 ppm</td><td>3(8.6... | <table><tr><td>Nyang’oma</td><td>Usigu</td><td>Overall</td></tr><tr><td>1.00±0.59</td><td>0.78±0.66</td><td>0.85±0.67</td></tr><tr><td>2.23</td><td>2.34</td><td>5.44</td></tr><tr><td>-</td><td>-</td><td>1(0.8%)</td></tr><tr><td>2(33.3%)</td><td>5(16.7)</td><td>14(10.9%)</td></tr><tr><td>0(0.0%)</td><td>4(13.3%)</td><td... |
adce0f4866f5d8a33c45a0080d15b0d91f423bfa196adda62b79919ad788b698.png | simple | <table><tr><td> </td><td>O<sub>2</sub><sup>−</sup> (nmol/mL)</td><td>H<sub>2</sub>O<sub>2</sub> (nmol/mL)</td><td>NO<sub>2</sub><sup>−</sup> (nmol/mL)</td><td>TBARS (<i>μ</i>mol/mL)</td></tr><tr><td>Control (<i>X</i> ± SE)</td><td>19.97 ± 0.45</td><td>20.28 ± 0.04</td><td>23.14 ± 1.... | <table><tr><td></td><td>O2− (nmol/mL)</td><td>H2O2 (nmol/mL)</td><td>NO2− (nmol/mL)</td><td>TBARS (μmol/mL)</td></tr><tr><td>Control (X ± SE)</td><td>19.97 ± 0.45</td><td>20.28 ± 0.04</td><td>23.14 ± 1.17</td><td>26.20 ± 0.38</td></tr></table> | <table><tr><td></td><td>O2− (nmol/mL)</td><td>H2O2 (nmol/mL)</td><td>NO2− (nmol/mL)</td><td>TBARS (μmol/mL)</td></tr><tr><td>DL-Hcy TLHC (X ± SE)</td><td>20.19 ± 0.47</td><td>20.23 ± 0.03</td><td>23.52 ± 1.13</td><td>25.88 ± 0.91</td></tr></table> |
93a6af8fdf251e1c46a5118114751393bbb263a2472d47f7caaf2635e5c787c8.png | simple | <table><tr><td>No.</td><td>Ab. <sup>1</sup></td><td>Ag.<sup>2</sup></td><td>Frequency</td><td>Redundancy</td></tr><tr><td>1</td><td>D</td><td>K</td><td>22.0% (13/59)</td><td>1.92 (25/13)</td></tr><tr><td>2</td><td>Y</td><td>E</td><td>18.6% (11/59)</td><td>2.45 (27/11)</td></tr><tr><td>3</td><td>Y</td><td>N</td><td>16.9... | <table><tr><td>No.</td><td>Ab. 1</td><td>Ag.2</td><td>Frequency</td><td>Redundancy</td></tr></table> | <table><tr><td>1</td><td>D</td><td>K</td><td>22.0% (13/59)</td><td>1.92 (25/13)</td></tr><tr><td>2</td><td>Y</td><td>E</td><td>18.6% (11/59)</td><td>2.45 (27/11)</td></tr><tr><td>3</td><td>Y</td><td>N</td><td>16.9% (10/59)</td><td>1.80 (18/10)</td></tr><tr><td>4</td><td>S</td><td>E</td><td>16.9% (10/59)</td><td>1.70 (1... |
e50eabb40c795592be455b2562a010876b2477eadf6833bae68a3215ac18364b.png | simple | <table><tr><td>Gene_symbol</td><td>Description</td><td>Log2 Ratio (A253-5/A253-0)</td><td><i>P</i> value</td></tr><tr><td>MAPK10</td><td>mitogen-activated protein kinase 10</td><td>−1.1440</td><td>0.000264947</td></tr><tr><td>AKT1</td><td>v-akt murine thymoma viral oncogene homolog 1</td><td>1.1076</td><td>0.0144... | <table><tr><td>Gene_symbol</td><td>Description</td><td>Log2 Ratio (A253-5/A253-0)</td><td>P value</td></tr><tr><td>MAPK10</td><td>mitogen-activated protein kinase 10</td><td>−1.1440</td><td>0.000264947</td></tr><tr><td>AKT1</td><td>v-akt murine thymoma viral oncogene homolog 1</td><td>1.1076</td><td>0.014492851</td></t... | <table><tr><td>COL4A1</td><td>collagen, type IV, alpha 1</td><td>2.1236</td><td>1.58011E-20</td></tr><tr><td>FN1</td><td>fibronectin 1</td><td>3.6490</td><td>3.35978E-24</td></tr><tr><td>THBS1</td><td>thrombospondin 1</td><td>1.0290</td><td>0.000135356</td></tr><tr><td>FLT1</td><td>fms-related tyrosine kinase 1</td><td... |
1c49f4043292bb10ee7ee84f3b413e7084ecad720e5b267409793196151fcf80.png | simple | <table><tr><td>Item</td><td><i>Mean</i></td><td><i>SD</i></td><td>Range</td><td>95% CI</td></tr><tr><td>1. I have a desire to succeed</td><td>4.6</td><td>0.62</td><td>1–5</td><td>4.56; 4.72</td></tr><tr><td>2. I have my own plan for how to stay or become well</td><td>3.9</td><td>0.92</td><td>1–5</td><td>3.8... | <table><tr><td>Item</td><td>Mean</td><td>SD</td><td>Range</td><td>95% CI</td></tr><tr><td>1. I have a desire to succeed</td><td>4.6</td><td>0.62</td><td>1–5</td><td>4.56; 4.72</td></tr><tr><td>2. I have my own plan for how to stay or become well</td><td>3.9</td><td>0.92</td><td>1–5</td><td>3.80; 4.05</td></tr><tr><td>3... | <table><tr><td>Item</td><td>Mean</td><td>SD</td><td>Range</td><td>95% CI</td></tr><tr><td>Reliance on others (mean of items 6, 22, 23 & 24)</td><td>4.0</td><td>0.68</td><td>2–5</td><td>3.88; 4.06</td></tr><tr><td>Not dominated by symptoms (mean of items 15, 16 & 17)</td><td>3.3</td><td>0.95</td><td>1–5</td><td>3.21; 3.... |
b5deaad4abb03646268095e9392bed62e1ff9beefb2d6987b6644e26c41128f5.png | complex | <table><tr><td>Study design</td><td>Methods & numbers</td><td>Research instruments</td><td>Respondents</td></tr><tr><td rowspan="4">Qualitative study</td><td rowspan="3">*GDs: 14 (One group from each hospital)</td><td rowspan="3">GD guideline: semi-structured open-ended questions with probes</td><td>From district h... | <table><tr><td>Study design</td><td>Methods & numbers</td><td>Research instruments</td><td>Respondents</td></tr><tr><td>Qualitative study</td><td>*GDs: 14 (One group from each hospital)</td><td>GD guideline: semi-structured open-ended questions with probes</td><td>From district hospitals: civil surgeon, obstetrics and ... | <table><tr><td rowspan="3">Qualitative study</td><td rowspan="2">*GDs: 14 (One group from each hospital)</td><td rowspan="2">GD guideline: semi-structured open-ended questions with probes</td><td>From MCWCs: deputy director of family planning, anesthesiologist, medical officer, one nurse, and one family welfare visitor... |
a22a752d03b3aeb78cd08e2c8c3740523e5fd3892a34786e75a9078b1e7be886.png | complex | <table><tr><td>Colorectal cancer characteristic</td><td>Black Mississippians</td><td>White Mississippians</td><td>Difference (Black–White)</td><td><i>P</i> value</td></tr><tr><td colspan="5">Statistically-significant health disparities</td></tr><tr><td> % (Age 50+) reporting NEVER had a sigmoidoscopy or colonosco... | <table><tr><td>Colorectal cancer characteristic</td><td>Black Mississippians</td><td>White Mississippians</td><td>Difference (Black–White)</td></tr><tr><td colspan="4">Statistically-significant health disparities</td></tr><tr><td>% (Age 50+) reporting NEVER had a sigmoidoscopy or colonoscopy (average: 2006, 2008 and 20... | <table><tr><td>P value</td></tr><tr><td>Statistically-significant health disparities</td></tr><tr><td><.0001</td></tr><tr><td><.0001</td></tr><tr><td>0.0001</td></tr><tr><td>0.0035</td></tr><tr><td>No discernible differences between groups</td></tr><tr><td>0.7926</td></tr></table> |
d00daff0ee42d66bca0b5dfb510d9f75c2617aaf19bd07d5ad3876e6490b41a8.png | simple | <table><tr><td>Database</td><td>Crops</td><td>Web link</td><td>Reference</td></tr><tr><td>Gramene</td><td>Grasses</td><td>http://www.gramene.org</td><td>Tello-Ruiz et al., 2016</td></tr><tr><td>International Rice Informatics Consortium</td><td>Rice (<i>Oryza sativa</i>)</td><td>http://iric.irri.org</td><td>n/a</td></tr... | <table><tr><td>Database</td><td>Crops</td><td>Web link</td><td>Reference</td></tr><tr><td>Gramene</td><td>Grasses</td><td>http://www.gramene.org</td><td>Tello-Ruiz et al., 2016</td></tr></table> | <table><tr><td>Database</td><td>Crops</td><td>Web link</td><td>Reference</td></tr><tr><td>International Rice Informatics Consortium</td><td>Rice (Oryza sativa)</td><td>http://iric.irri.org</td><td>n/a</td></tr><tr><td>Maize Genetics and Genomics Database</td><td>Maize (Zea mays)</td><td>http://www.maizegdb.org</td><td>... |
09e3701deed89375299d89de42b4748e9f63d2a554870d081adda0b62d6544d2.png | simple | <table><tr><td> </td><td>One missing</td><td>Two missing</td><td>Three missing</td><td>Four missing</td><td>No missing</td><td>Total</td></tr><tr><td><i>Sex</i></td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Female</td><td>277 (18.3%)</td><td>131 (8.6%)</td><td>89 (5.9%)</td><td>77 (5.1%)<... | <table><tr><td></td><td>One missing</td><td>Two missing</td><td>Three missing</td><td>Four missing</td><td>No missing</td><td>Total</td></tr><tr><td>Sex</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Female</td><td>277 (18.3%)</td><td>131 (8.6%)</td><td>89 (5.9%)</td><td>77 (5.1%)</td><td>933 (6... | <table><tr><td>5</td><td>.9%)</td><td></td><td>.8%)</td><td></td><td>5 (28.9%)</td><td>1 (100%)</td></tr><tr><td>16–30</td><td>108 (20.8%)</td><td>13 (2.5%)</td><td>0 (0%)</td><td>0 (0%)</td><td>398 (76.6%)</td><td>519 (100%)</td></tr><tr><td>31–45</td><td>115 (19.1%)</td><td>84 (13.9%)</td><td>29 (4.8%)</td><td>2 (0.3... |
2872f7c042f7df880e88a94ad818573c466db2e4f40434cee9ab9dbe3eb1bf5f.png | simple | <table><tr><td> </td><td>Age mean</td><td> </td><td>Visits before</td><td>Visits after</td><td>Visitors before</td><td>Visitors after</td><td>Change visits</td><td>Change visitors</td></tr><tr><td> </td><td> </td><td> </td><td>(2 years)</td><td>(2 years)</td><td> </td><td> </td><td>n (%)</td><td>n (%)</td></tr><tr><td>... | <table><tr><td></td><td>Age mean</td><td></td><td>Visits before</td><td>Visits after</td><td>Visitors before</td><td>Visitors after</td><td>Change visits</td><td>Change visitors</td></tr><tr><td></td><td></td><td></td><td>(2 years)</td><td>(2 years)</td><td></td><td></td><td>n (%)</td><td>n (%)</td></tr><tr><td>Men 25-... | <table><tr><td></td><td></td><td>Visits before</td><td>Visits after</td><td>Visitors before</td><td>Visitors after</td><td>Change visits</td><td>Change visitors</td></tr><tr><td></td><td></td><td>(2 years)</td><td>(2 years)</td><td></td><td></td><td>n (%)</td><td>n (%)</td></tr><tr><td>Income below median</td><td>51788... |
8bb52441077fd94f2066c1bf9253147eba12b92657766112d0531817302906b7.png | simple | <table><tr><td>Family</td><td>Name</td><td>Local RDB</td><td>National RL rank</td><td>Main habitat</td><td>Life forms</td></tr><tr><td>Azollaceae</td><td><i>Azolla japonica</i></td><td>35</td><td>VU</td><td>Paddy, Ditch</td><td>perennial fern</td></tr><tr><td>Hydrocharitaceae</td><td><i>Blyxa echinosperma</i></td><td>4... | <table><tr><td>Family</td><td>Name</td><td>Local RDB</td><td>National RL rank</td></tr><tr><td>Azollaceae</td><td>Azolla japonica</td><td>35</td><td>VU</td></tr><tr><td>Hydrocharitaceae</td><td>Blyxa echinosperma</td><td>42</td><td>VU</td></tr><tr><td>Alismataceae</td><td>Caldesia parnassifolia</td><td>37</td><td>VU</t... | <table><tr><td>Main habitat</td><td>Life forms</td></tr><tr><td>Paddy, Ditch</td><td>perennial fern</td></tr><tr><td>Paddy, Ditch</td><td>annual</td></tr><tr><td>Pond, Lake, Paddy</td><td>perennial</td></tr><tr><td>Forest edge</td><td>annual</td></tr><tr><td>Pond, Paddy, Ditch</td><td>perennial fern</td></tr><tr><td>Gr... |
0d6889725e571208af7b45de7387b6b64352ea6b3d40e9f674f80a1e7a993377.png | complex | <table><tr><td rowspan="2">Rat number</td><td colspan="2">Control group</td><td colspan="2">Cyanoacrylate group</td></tr><tr><td>Researcher 1</td><td>Researcher 2</td><td>Researcher 1</td><td>Researcher 2</td></tr><tr><td>1</td><td>0</td><td>0</td><td>1</td><td>1</td></tr><tr><td>2</td><td>0</td><td>0</td><td>0</td><td... | <table><tr><td rowspan="2">Rat number</td><td colspan="2">Control group</td><td colspan="2">Cyanoacrylate group</td></tr><tr><td>Researcher 1</td><td>Researcher 2</td><td>Researcher 1</td><td>Researcher 2</td></tr><tr><td>1</td><td>0</td><td>0</td><td>1</td><td>1</td></tr><tr><td></td><td>0</td><td></td><td></td><td>0<... | <table><tr><td rowspan="2">Rat number</td><td colspan="2">Control group</td><td colspan="2">Cyanoacrylate group</td></tr><tr><td>Researcher 1</td><td>Researcher 2</td><td>Researcher 1</td><td>Researcher 2</td></tr><tr><td>2</td><td></td><td>0</td><td>0</td><td></td></tr><tr><td>3</td><td>2</td><td>2</td><td>1</td><td>2... |
2ca1063a8f8d8194175e2237667975c5a24bc526ba919a15b7c614d2a85c8417.png | complex | <table><tr><td>SSP no.</td><td>Accession no.</td><td>Protein Description</td><td>Mass in kDa (experiment/predicted)</td><td>pI (experiment/predicted)</td><td>Sequence coverage (%)</td><td>Number of peptides matched</td><td>Mowse score</td><td>Error (ppm)</td></tr><tr><td colspan="9">pH 4–7</td></tr><tr><td>2120</... | <table><tr><td>SSP no.</td><td>Accession no.</td><td>Protein Description</td><td>Mass in kDa (experiment/predicted)</td><td>pI (experiment/predicted)</td><td>Sequence coverage (%)</td><td>Number of peptides matched</td><td>Mowse score</td><td>Error (ppm)</td></tr></table> | <table><tr><td colspan="9">pH 4–7</td></tr><tr><td>2120</td><td>6065880</td><td>Heterogeneous nuclear ribonucleoprotein H2</td><td>38.43/49.52</td><td>3.96/5.89</td><td>46</td><td>15</td><td>171</td><td>14</td></tr><tr><td>3609</td><td>515634</td><td>Ubiquinol-cytochrome-c reductase complex core protein I, mitochondria... |
71b1b48a3eeb8698a5830fa2c0349c9b22ef21747db8267c20be25134dc69145.png | complex | <table><tr><td></td><td>Control (<i>n</i> = 20)</td><td>Imagery (<i>n</i> = 20)</td></tr><tr><td></td><td>mean ± <i>SD</i></td><td>mean ± <i>SD</i></td></tr><tr><td colspan="3">Did you ....</td></tr><tr><td>... feel your imagery improved? <i>(1: not at all, 7: considerably)</i></td><td>5.45 ± 1.10</td><t... | <table><tr><td></td><td>Control (n = 20)</td><td>Imagery (n = 20)</td></tr><tr><td></td><td>mean ± SD</td><td>mean ± SD</td></tr><tr><td colspan="3">Did you ....</td></tr><tr><td>... feel your imagery improved? (1: not at all, 7: considerably)</td><td>5.45 ± 1.10</td><td>5.80 ± 0.77</td></tr></table> | <table><tr><td></td><td>Control (n = 20)</td><td>Imagery (n = 20)</td></tr><tr><td></td><td>mean ± SD</td><td>mean ± SD</td></tr><tr><td>... image as instructed and practiced? **(1: not at all, 7: exactly)</td><td>5.65 ± 0.67</td><td>6.20 ± 0.70</td></tr><tr><td>... notice any movement in the non-dominant hand? (1:not ... |
3a6ed17ca0d3474d9e2a40c62fc53608bab43dbcd3f10cf810067d2172c3e621.png | simple | <table><tr><td>Parameter</td><td>Activity rate</td><td>Time (%) in novel</td><td>Crossing/min</td></tr><tr><td>VEH controls</td><td>3.79 ± 0.21</td><td>79.7 ± 1.09</td><td>2.55 ± 0.26</td></tr><tr><td>DAT-i mice</td><td>4.10 ± 0.22</td><td>78.6 ± 1.75</td><td>2.98 ± 0.33</td></tr></table> | <table><tr><td>Parameter</td><td>Activity rate</td><td>Time (%) in novel</td><td>Crossing/min</td></tr></table> | <table><tr><td>VEH controls</td><td>3.79 ± 0.21</td><td>79.7 ± 1.09</td><td>2.55 ± 0.26</td></tr><tr><td>DAT-i mice</td><td>4.10 ± 0.22</td><td>78.6 ± 1.75</td><td>2.98 ± 0.33</td></tr></table> |
90ce70b4a7d6bc84d3e98f7d8609538cda8b331f4eccfc8268c2cd598502f63b.png | complex | <table><tr><td>GO ID<sup>1</sup></td><td colspan="7"><i>p</i>-values</td><td>GO group description</td></tr><tr><td></td><td>[1, 10-<sup>2</sup>)</td><td>[10<sup>-2</sup>, 10<sup>-5</sup>)</td><td>[10<sup>-5</sup>, 10<sup>-10</sup>)</td><td>[10<sup>-10</sup>, 10<sup>-20</sup>)</td><td>[10<sup>-20</sup>, 10<sup>-50</sup>... | <table><tr><td>GO ID1</td><td colspan="7">p-values</td><td>GO group description</td></tr><tr><td></td><td>[1, 10-2)</td><td>[10-2, 10-5)</td><td>[10-5, 10-10)</td><td>[10-10, 10-20)</td><td>[10-20, 10-50)</td><td>[10-50, 10-100)</td><td>[10-100, 0]</td><td></td></tr><tr><td>* GO0005215(392)</td><td>94.13</td><td>3.68</... | <table><tr><td>GO ID1</td><td colspan="7">p-values</td><td>GO group description</td></tr><tr><td></td><td>[1, 10-2)</td><td>[10-2, 10-5)</td><td>[10-5, 10-10)</td><td>[10-10, 10-20)</td><td>[10-20, 10-50)</td><td>[10-50, 10-100)</td><td>[10-100, 0]</td><td></td></tr><tr><td>*** GO0042625(30)</td><td>85.75</td><td>1.84<... |
84a3ba89559b5f95cd847b609f466f8c09cfc7aadc7a4dab8d3551a1c8264b76.png | complex | <table><tr><td>Primers</td><td>Sequence (5′-3′)</td></tr><tr><td colspan="2">Primers for gene disruption and complementation</td></tr><tr><td> LwblA-F</td><td>AAGCTTTCGGGTACGCCATCTCGTA</td></tr><tr><td> LwblA-R</td><td>TCTAGAGCTGCTCCCTGAACGAACA</td></tr><tr><td> RwblA-F</td><td>GGATCCACGACGAGGTGTACGAGAAC</t... | <table><tr><td>Primers</td><td>Sequence (5′-3′)</td></tr><tr><td colspan="2">Primers for gene disruption and complementation</td></tr><tr><td>LwblA-F</td><td>AAGCTTTCGGGTACGCCATCTCGTA</td></tr><tr><td>LwblA-R</td><td>TCTAGAGCTGCTCCCTGAACGAACA</td></tr><tr><td>RwblA-F</td><td>GGATCCACGACGAGGTGTACGAGAAC</td></tr><tr><td>... | <table><tr><td>Primers</td><td>Sequence (5′-3′)</td></tr><tr><td>CwblA-R</td><td>TCTAGAAGCACACTGACACCGAGGAACTTGGC</td></tr><tr><td colspan="2">Primers for qRT-PCR</td></tr><tr><td>RTsanG-F</td><td>GGCGTACACAGCTCAAGAGC</td></tr><tr><td>RTsanG-R</td><td>AATTCGTCGATGAGCTGATC</td></tr><tr><td>RTsanN-F</td><td>AGATCATGCGCTC... |
ea60a12b428d7e870fcb3abfcf3e5727ae7d1b12acaf3348a548bd2e88dcba33.png | complex | <table><tr><td rowspan="2">Time (weeks)</td><td colspan="5">Chemical composition</td></tr><tr><td>Ash</td><td>Crude protein</td><td>Cellulose</td><td>Hemicellulose</td><td>Lignin</td></tr><tr><td>0</td><td>54.0 d</td><td>32.8 d</td><td>470.6 c</td><td>299.4 a</td><td>79.1 ab</td></tr><tr><td>1</td><td> 56.1 cd</td><td>... | <table><tr><td rowspan="2">Time (weeks)</td><td colspan="2">Chemical composition</td></tr><tr><td>Ash</td><td>Crude protein</td></tr><tr><td>0</td><td>54.0 d</td><td>32.8 d</td></tr><tr><td>1</td><td>56.1 cd</td><td>34.3 cd</td></tr><tr><td>2</td><td>58.4 c</td><td>36.0 bc</td></tr><tr><td>3</td><td>61.2 b</td><td>36.0... | <table><tr><td colspan="3">Chemical composition</td></tr><tr><td>Cellulose</td><td>Hemicellulose</td><td>Lignin</td></tr><tr><td>470.6 c</td><td>299.4 a</td><td>79.1 ab</td></tr><tr><td>470.7 c</td><td>293.9 ab</td><td>82.4 a</td></tr><tr><td>485.7 ab</td><td>279.7 bc</td><td>83.6 a</td></tr><tr><td>489.8 ab</td><td>26... |
14334f24c9e1f32ff9a6b918d1f28d17624949a7fea1ffb2cab37e0e344358b7.png | complex | <table><tr><td rowspan="2">Gene Locus ID</td><td rowspan="2">Gene description</td><td colspan="3">Normalized Fold (Log<sub>2</sub>)</td></tr><tr><td>P</td><td>HC</td><td>PHC</td></tr><tr><td><i>GSVIVT00016386001</i></td><td>Vitis vinifera respiratory burst oxidase homolog protein E (VvRBOHE)</td><td>0.30 ± 0.21</t... | <table><tr><td rowspan="2">Gene Locus ID</td><td rowspan="2">Gene description</td><td colspan="3">Normalized Fold (Log2)</td></tr><tr><td>P</td><td>HC</td><td>PHC</td></tr><tr><td>GSVIVT00016386001</td><td>Vitis vinifera respiratory burst oxidase homolog protein E (VvRBOHE)</td><td>0.30 ± 0.21</td><td>1.11 ± 0.18</td><... | <table><tr><td>GSVIVT00007083001</td><td>Vitis vinifera superoxide dismutase [Fe] 3, chloroplastic (VvFSD3)</td><td>0.40 ± 0.17</td><td>0.17 ± 0.10</td><td>1.82 ± 0.11</td></tr><tr><td>GSVIVT00014163001</td><td>Vitis vinifera superoxide dismutase [Fe], chloroplastic (VvFSD)</td><td>0.50 ± 0.13</td><td>0.33 ± 0.22</td><... |
adae28cb71a0befdaa26bb2f277ae6de01b925698165f3b191bee9c9dadd97c9.png | simple | <table><tr><td>Short Name</td><td>Designation after VDA 239-100</td><td>Thickness in mm</td></tr><tr><td>DP600</td><td>CR330Y590T-DP-GI50/50-U</td><td>1.00</td></tr><tr><td>DH600</td><td>CR330Y590T-DH-GI50/50-U</td><td>1.00</td></tr><tr><td>DP800</td><td>CR440Y780T-DP-GI50/50-U</td><td>1.00</td></tr><tr><td>DH800</td><... | <table><tr><td>Short Name</td><td>Designation after VDA 239-100</td><td>Thickness in mm</td></tr><tr><td>DP600</td><td>CR330Y590T-DP-GI50/50-U</td><td>1.00</td></tr><tr><td>DH600</td><td>CR330Y590T-DH-GI50/50-U</td><td>1.00</td></tr><tr><td>DP800</td><td>CR440Y780T-DP-GI50/50-U</td><td>1.00</td></tr><tr><td>DH800</td><... | <table><tr><td></td><td>0T-CH-EG53/53-U1</td><td>.20</td></tr><tr><td>DH1200</td><td>CR850Y1180T-DH-EG53/53-U1</td><td>1.00</td></tr><tr><td>CP1200</td><td>CR900Y1180T-CP-EG53/53-U</td><td>1.20</td></tr><tr><td>CH1200</td><td>CR900Y1180T-CH-UC-U1</td><td>1.00</td></tr></table> |
8a73cb5b3d72e17ea8f51819e427ccdde2862997153fb6fd944ed29484716658.png | complex | <table><tr><td>Background characteristics</td><td colspan="2">Infants starting the intervention (N = 86)</td><td colspan="2">Infants completing 3 weeks (N = 81)</td></tr><tr><td></td><td>Acupuncture group (n = 46)</td><td>Control group (n = 40)</td><td>Acupuncture group (n = 43)</td><td>Control group (n = 38)</td></tr>... | <table><tr><td>Background characteristics</td><td colspan="2">Infants starting the intervention (N = 86)</td><td colspan="2">Infants completing 3 weeks (N = 81)</td></tr><tr><td></td><td>Acupuncture group (n = 46)</td><td>Control group (n = 40)</td><td>Acupuncture group (n = 43)</td><td>Control group (n = 38)</td></tr>... | <table><tr><td>Solely breastfed, n (%)</td><td>35 (76)</td><td>26 (65)</td><td>32 (74)</td><td>25 (66)</td></tr><tr><td>Having a parent and/or sibling with food intolerance/allergy, n (%)</td><td>17 (37)</td><td>18 (45)</td><td>15 (35)</td><td>17 (45)</td></tr><tr><td>Having a parent and/or sibling who had had infantil... |
1b9664c4d55b199ddb4ab59a3610d8548bff929aadae80a1cc1fe5ebbf166859.png | simple | <table><tr><td></td><td>1995</td><td>2001</td><td>Change %</td></tr><tr><td>Admitted patients/doctor/year</td><td>101</td><td>87</td><td>-13.9</td></tr><tr><td>Admitted patients/nurse/year</td><td>24</td><td>22</td><td>-8.3</td></tr><tr><td>Admitted patients/office staff/year</td><td>106</td><td>83</td><td>-21.7</td></... | <table><tr><td></td><td>1995</td><td>2001</td><td>Change %</td></tr><tr><td>Admitted patients/doctor/year</td><td>101</td><td>87</td><td>-13.9</td></tr><tr><td>Admitted patients/nurse/year</td><td>24</td><td>22</td><td>-8.3</td></tr><tr><td>Admitted patients/office staff/year</td><td>106</td><td>83</td><td>-21.7</td></... | <table><tr><td> surgery</td><td>151</td><td>4</td><td>11.4</td></tr><tr><td>Orthopedic surgery</td><td>189</td><td>155</td><td>-18.0</td></tr><tr><td>Neurosurgery</td><td>98</td><td>100</td><td>+2.0</td></tr><tr><td>Otorhinolaryngology</td><td>177</td><td>125</td><td>-29.4</td></tr><tr><td>Ophthalmology</td><td>135</td... |
750da053aa87a696d487451bfb514006e0f75063b27218bd994fd64f1b452a7f.png | complex | <table><tr><td rowspan="2">Drug</td><td rowspan="2">UDS proportion (95% CI)*</td><td colspan="3">CASI</td></tr><tr><td>Past 7 days</td><td>Past 6 months</td><td>Lifetime</td></tr><tr><td>Any drugs</td><td>53.5 (47.0-60.0)</td><td>42.0<sup>‡</sup></td><td>59.3</td><td>92.4</td></tr><tr><td>Marijuana</td><td>36.0 (... | <table><tr><td rowspan="2">Drug</td><td rowspan="2">UDS proportion (95% CI)*</td><td colspan="3">CASI</td></tr><tr><td>Past 7 days</td><td>Past 6 months</td><td>Lifetime</td></tr><tr><td>Any d</td><td>53.5 </td><td>42.</td><td>5</td><td>92.4</td></tr></table> | <table><tr><td rowspan="2">Drug</td><td rowspan="2">UDS proportion (95% CI)*</td><td colspan="3">CASI</td></tr><tr><td>Past 7 days</td><td>Past 6 months</td><td>Lifetime</td></tr><tr><td>rugs</td><td>(47.0-60.0)</td><td>0‡</td><td>9.3</td><td></td></tr><tr><td>Marijuana</td><td>36.0 (29.7-42.3)</td><td>28.6‡</td><td>44... |
be6f10ce94c5f0768eb70d95a649e59076c5ba6f3f9fa962548f4654d3f81299.png | simple | <table><tr><td>Outcome</td><td><i>P</i> value</td></tr><tr><td>Arthralgia</td><td>0.390</td></tr><tr><td>Bone pain</td><td>0.608</td></tr><tr><td>Back pain</td><td>0.744</td></tr><tr><td>Pain in extremity</td><td>0.056</td></tr><tr><td>Myalgia</td><td>0.794</td></tr><tr><td>LS BMD 12 months (normal at baseline-ZOL tria... | <table><tr><td>Outcome</td><td>P value</td></tr><tr><td>Arthralgia</td><td>0.390</td></tr><tr><td>Bone pain</td><td>0.608</td></tr><tr><td>Back pain</td><td>0.744</td></tr><tr><td>Pain in extremity</td><td>0.056</td></tr><tr><td>Myalgia</td><td>0.794</td></tr></table> | <table><tr><td>Outcome</td><td>P value</td></tr><tr><td>LS BMD 12 months (normal at baseline-ZOL trials)</td><td>0.0003</td></tr><tr><td>LS BMD 12 months (osteopenic at baseline-ZOL trials)</td><td>0.296</td></tr><tr><td>LS BMD 12 months (residronate and ibandronate trials)</td><td>0.345</td></tr></table> |
ce7fac0186611e4da90c589e6ce2445367b7ee2f4f97bff70df642e7c2347f00.png | complex | <table><tr><td rowspan="2">Categories</td><td colspan="2">First-line treatment (XELOX plus bevacizumab)</td><td colspan="2">Second-line treatment (FOLFIRI)</td><td colspan="2">Clinical Support</td><td colspan="2">Death</td></tr><tr><td>R$</td><td>%</td><td>R$</td><td>%</td><td>R$</td><td>%</td><td>R$</td><td>%</td></tr... | <table><tr><td rowspan="2">Categories</td><td colspan="2">First-line treatment (XELOX plus bevacizumab)</td><td colspan="2">Second-line treatment (FOLFIRI)</td><td colspan="2">Clinical Support</td><td colspan="2">Death</td></tr><tr><td>R$</td><td>%</td><td>R$</td><td>%</td><td>R$</td><td>%</td><td>R$</td><td>%</td></tr... | <table><tr><td>Medications</td><td>27,592.00</td><td>89.57</td><td>4327.80</td><td>33.33</td><td>0.00</td><td>0.00</td><td>0.00</td><td>0.00</td></tr><tr><td>Preparation (Pharmacy)</td><td>120.08</td><td>0.39</td><td>270.18</td><td>2.08</td><td>0.00</td><td>0.00</td><td>0.00</td><td>0.00</td></tr><tr><td>Administration... |
a13d929c9c005f9192fb5fcb71b44772fd3f0f0b92b91520d1bbd0a4751f1870.png | complex | <table><tr><td>Genotypes</td><td colspan="3">Normotensives</td><td colspan="3">Hypertensive free from current antihypertensive medication</td><td colspan="3">Current use of antihypertensive medication</td></tr><tr><td></td><td>N</td><td>SBP(mm Hg)</td><td>DBP(mm Hg)</td><td>N</td><td>SBP(mm Hg)</td><td>DBP(mm Hg)</td><... | <table><tr><td>Genotypes</td><td colspan="3">Normotensives</td><td colspan="3">Hypertensive free from current antihypertensive medication</td><td colspan="3">Current use of antihypertensive medication</td></tr><tr><td></td><td>N</td><td>SBP(mm Hg)</td><td>DBP(mm Hg)</td><td>N</td><td>SBP(mm Hg)</td><td>DBP(mm Hg)</td><... | <table><tr><td>p values</td><td></td><td>0.207</td><td>0.286</td><td></td><td>0.647</td><td>0.897</td><td></td><td>0.023</td><td>0.426</td></tr><tr><td>+2962A/G genotypes</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>+2962A/A</td><td>429</td><td>120.5(0.5)</td><td>77.... |
d0078c44e851be13ecc6c117adc1d12d5407888bdd169920d7008a69125228d5.png | simple | <table><tr><td>Gene</td><td>SNP<sup><i>a</i></sup></td><td>AA change<sup><i>b</i></sup></td><td>Protein domain<sup><i>c</i></sup></td><td>dbSNP ID</td></tr><tr><td><i>TLR2</i></td><td>42 C > T</td><td>Silent 14</td><td>-<sup><i>d</i></sup></td><td>rs1388116474:C > T</td></tr><tr><td></td><td>53 C > T</td><td>M... | <table><tr><td>Gene</td><td>SNPa</td><td>AA changeb</td><td>Protein domainc</td><td>dbSNP ID</td></tr><tr><td>TLR2</td><td>42 C > T</td><td>Silent 14</td><td>-d</td><td>rs1388116474:C > T</td></tr><tr><td></td><td>53 C > T</td><td>M18T</td><td>-</td><td>rs1388116475:C > T</td></tr><tr><td></td><td>108 C > T</td><td>Sil... | <table><tr><td>Gene</td><td>SNPa</td><td>AA changeb</td><td>Protein domainc</td><td>dbSNP ID</td></tr><tr><td></td><td>1650 G > A</td><td>Silent 550</td><td>LRR_CT</td><td>rs1388116486:G > A</td></tr><tr><td></td><td>1678 A > G</td><td>A560T</td><td>LRR_CT</td><td>rs1388116487:A > G</td></tr><tr><td></td><td>1707 C > T... |
4f23349c221908ae8fb36063038e9a31250b34dba5092a864ca79ac0e500315a.png | complex | <table><tr><td>Age group</td><td colspan="2">HIV-positive children n = 123</td><td colspan="2">HIV-uninfected children n = 192</td><td>Total</td></tr><tr><td>Months</td><td>Male</td><td>Female</td><td>Male</td><td>Female</td><td></td></tr><tr><td>0–5.9</td><td>1</td><td>2</td><td>4</td><td>4</td><td>11</td></tr><... | <table><tr><td>Age group</td><td colspan="2">HIV-positive children n = 123</td><td>HIV-uninfected children n = 192</td></tr><tr><td>Months</td><td>Male</td><td>Female</td><td>Male</td></tr><tr><td>0–5.9</td><td>1</td><td>2</td><td>4</td></tr><tr><td>6–11.9</td><td>15</td><td>8</td><td>21</td></tr><tr><td>12–23.9</td><t... | <table><tr><td>HIV-uninfected children n = 192</td><td>Total</td></tr><tr><td>Female</td><td></td></tr><tr><td>4</td><td>11</td></tr><tr><td>14</td><td>58</td></tr><tr><td>37</td><td>160</td></tr><tr><td>6</td><td>50</td></tr><tr><td>6</td><td>20</td></tr><tr><td>4</td><td>16</td></tr><tr><td>71</td><td>315</td></tr></... |
067abe9eb7b9571d016bcb4f8dabd671efd62ed0840f37a3911787ee461ec0be.png | simple | <table><tr><td>Factor</td><td>Cronbach's alpha</td><td>Number of items</td></tr><tr><td>Privacy</td><td>.756</td><td>3</td></tr><tr><td>Culture</td><td>.926</td><td>3</td></tr><tr><td>Attitude toward telemedicine </td><td>.755</td><td>3</td></tr><tr><td>Benefit</td><td>.729</td><td>5</td></tr><tr><td>Connectivity </td>... | <table><tr><td>Factor</td><td>Cronbach's alpha</td><td>Number of items</td></tr><tr><td>Privacy</td><td>.756</td><td>3</td></tr><tr><td>Culture</td><td>.926</td><td>3</td></tr><tr><td>Attitude toward telemedicine</td><td>.755</td><td>3</td></tr><tr><td>Benefit</td><td>.729</td><td>5</td></tr><tr><td>Connectivity</td><t... | <table><tr><td>Factor</td><td>Cronbach's alpha</td><td>Number of items</td></tr><tr><td>Upper-level leadership</td><td>.818</td><td>3</td></tr></table> |
1eb5b90792141699df09568eb29e954df6aaf852bd53d0d395d009d79646bedd.png | complex | <table><tr><td rowspan="2">Variables/Group</td><td colspan="2">Control (<i>n</i> = 15)</td><td colspan="2">TKD (<i>n</i> = 15)</td><td colspan="2">Time × Group Interaction</td></tr><tr><td>Baseline</td><td>16-Week</td><td>Baseline</td><td>16-Week</td><td><i>F</i></td><td><i>p</i></td></tr><tr><td>Word test (score)... | <table><tr><td rowspan="2">Variables/Group</td><td colspan="2">Control (n = 15)</td><td colspan="2">TKD (n = 15)</td></tr><tr><td>Baseline</td><td>16-Week</td><td>Baseline</td><td>16-Week</td></tr><tr><td>Word test (score)</td><td>44.67 ± 10.89</td><td>45.33 ± 9.06</td><td>45.87 ± 8.62</td><td>47.60 ± 7.73</td></tr><tr... | <table><tr><td colspan="2">Time × Group Interaction</td></tr><tr><td>F</td><td>p</td></tr><tr><td>1.029</td><td>0.319</td></tr><tr><td></td><td></td></tr><tr><td>2.429</td><td>0.130</td></tr><tr><td></td><td></td></tr><tr><td>13.952</td><td>0.001 **</td></tr><tr><td></td><td></td></tr></table> |
86d74620b4e9bac05ee01a60243e7151ecaba8988c090126a5d8fd718a4e7f59.png | simple | <table><tr><td> </td><td>Patients (<i>n</i> = 38)</td><td>Controls (<i>n</i> = 23)</td></tr><tr><td>Median age (range) years</td><td>37 (18 to 50)</td><td>36 (24 to 49)</td></tr><tr><td>Sex distribution</td><td>26 F/12 M</td><td>15 F/7 M</td></tr><tr><td>CIS/MS at 12 months</td><td>19/19</td><td>—</td></tr><tr><t... | <table><tr><td></td><td>Patients (n = 38)</td><td>Controls (n = 23)</td></tr><tr><td>Median age (range) years</td><td>37 (18 to 50)</td><td>36 (24 to 49)</td></tr><tr><td>Sex distribution</td><td>26 F/12 M</td><td>15 F/7 M</td></tr><tr><td>CIS/MS at 12 months</td><td>19/19</td><td>—</td></tr></table> | <table><tr><td>Median lesion volume (range) mL</td><td>0.54 (0 to 38.1)</td><td>—</td></tr><tr><td>Median number of new lesions</td><td>1 (0 to 4)</td><td>—</td></tr><tr><td>Median OR lesion volume (range) mL</td><td>0.06 (0 to 21.3)</td><td>—</td></tr></table> |
c92daa86b66e53a152a5ee1216397535b23fb0c93865cdf5b2ccce4880608a02.png | complex | <table><tr><td>Construct</td><td>Measure</td><td>Administration</td></tr><tr><td colspan="3"><i>Primary Outcome measure</i></td></tr><tr><td>Symptom Severity</td><td>Irritable Bowel Symptom Severity Scale</td><td>Pre, 2 wk, 3 mo, 6 mo, 12 mo post</td></tr><tr><td colspan="3"><i>Secondary Outcome measures</i></td></tr><... | <table><tr><td>Construct</td><td>Measure</td><td>Administration</td></tr><tr><td colspan="3">Primary Outcome measure</td></tr><tr><td>Symptom Severity</td><td>Irritable Bowel Symptom Severity Scale</td><td>Pre, 2 wk, 3 mo, 6 mo, 12 mo post</td></tr><tr><td colspan="3">Secondary Outcome measures</td></tr><tr><td>Symptom... | <table><tr><td>Catalogue of distressing prior events</td><td>Family Inventory of Life Events (FILE)</td><td>Pre intervention only</td></tr><tr><td>Demographics</td><td>Age, race, education, marital status, income</td><td>Pre intervention only</td></tr><tr><td colspan="3">Process measures</td></tr><tr><td>Measure of min... |
edfa6611afe9e03557514a159ce2157916cb4adb13ecb9d7919f679f03bbe940.png | simple | <table><tr><td>Organizations</td><td>Carbohydrates</td><td>Fiber</td><td>Protein</td><td>Fat</td></tr><tr><td>American Diabetes Association (ADA)</td><td>50–60%</td><td>Not specified</td><td>10–15%</td><td>30–35%</td></tr><tr><td>The British Diabetic Association/Diabetes UK</td><td>45–60%</td><t... | <table><tr><td>Organizations</td><td>Carbohydrates</td><td>Fiber</td><td>Protein</td><td>Fat</td></tr><tr><td>American Diabetes Association (ADA)</td><td>50–60%</td><td>Not specified</td><td>10–15%</td><td>30–35%</td></tr></table> | <table><tr><td>The British Diabetic Association/Diabetes UK</td><td>45–60%</td><td><30 g/day</td><td>30–35%</td><td><35%</td></tr><tr><td>European Association for the Study of Diabetes (EASD)</td><td>45–60%</td><td>Increase fiber with low-GI food</td><td>10–20%</td><td>35%</td></tr><tr><td>The Canadian Diabetes Associa... |
c9858aea0d5c69da7ef0f9477e69bfb7c90c34463e6f79b35fe7a8734f2c9c93.png | simple | <table><tr><td>Gene</td><td>Reagent Sequences</td></tr><tr><td>MIP-1α</td><td>F; AGCTGACACCCCGACTGC</td></tr><tr><td></td><td>R; GTCAACGATGAATTGGCGTG</td></tr><tr><td></td><td>P; TGCTGCTTCTCCTACAGCCGGAAGAT</td></tr><tr><td>MIP-1β</td><td>F; AGCTCTGCGTGTCTGCCC T</td></tr><tr><td></td><td>R; GCTGAGAACCCTAGAGCAC... | <table><tr><td>Gene</td></tr><tr><td>MIP-1α</td></tr><tr><td></td></tr><tr><td></td></tr><tr><td>MIP-1β</td></tr><tr><td></td></tr><tr><td></td></tr><tr><td>TNFα</td></tr><tr><td></td></tr><tr><td></td></tr><tr><td>iNOS</td></tr><tr><td></td></tr><tr><td></td></tr><tr><td>IL-1β</td></tr><tr><td></td></tr><tr><td></td><... | <table><tr><td>Reagent Sequences</td></tr><tr><td>F; AGCTGACACCCCGACTGC</td></tr><tr><td>R; GTCAACGATGAATTGGCGTG</td></tr><tr><td>P; TGCTGCTTCTCCTACAGCCGGAAGAT</td></tr><tr><td>F; AGCTCTGCGTGTCTGCCC T</td></tr><tr><td>R; GCTGAGAACCCTAGAGCACA</td></tr><tr><td>P; TCTCCT CTTGCTCGTGGCTGCCTT</td></tr><tr><td>F; TCCAGGCGGTGC... |
2da1995d658ceb3307b1f710b49349cc55b27cbc3d08085cc03c930f155146bd.png | simple | <table><tr><td>Sexual behaviors</td><td>Number (%)</td></tr><tr><td>Diagnosed with an STI in the past 6 months</td><td>16 (10.8)</td></tr><tr><td>Sought treatment for most recent STI symptom (<i>n</i> = 16)</td><td>2 (11.1)</td></tr><tr><td>Facility where the most recent STI was treated</td><td></td></tr><tr><td> Publi... | <table><tr><td>Sexual behaviors</td><td>Number (%)</td></tr><tr><td>Diagnosed with an STI in the past 6 months</td><td>16 (10.8)</td></tr><tr><td>Sought treatment for most recent STI symptom (n = 16)</td><td>2 (11.1)</td></tr><tr><td>Facility where the most recent STI was treated</td><td></td></tr><tr><td>Public health... | <table><tr><td>n last sexual intercourse (n = 59)</td><td>.6)</td></tr><tr><td>Had sexual intercourse when intoxicated (n = 59)</td><td>22 (37.3)</td></tr></table> |
1968857311b2029fe0b187b7e51414e7cbf3d2620daf87eb32e475ebab61c369.png | complex | <table><tr><td></td><td colspan="3">up to 30</td><td colspan="3">from 31 to 60</td><td colspan="3">over 61</td><td colspan="3">Male</td><td colspan="3">Female</td></tr><tr><td></td><td>%</td><td colspan="2">95% C.I.</td><td>%</td><td colspan="2">95% C.I.</td><td>%</td><td colspan="2">95% C.I.</td><td>%</td><td colspan=... | <table><tr><td></td><td colspan="3">up to 30</td><td colspan="3">from 31 to 60</td><td colspan="3">over 61</td><td colspan="3">Male</td><td colspan="3">Female</td></tr><tr><td></td><td>%</td><td colspan="2">95% C.I.</td><td>%</td><td colspan="2">95% C.I.</td><td>%</td><td colspan="2">95% C.I.</td><td>%</td><td colspan=... | <table><tr><td></td><td colspan="3">up to 30</td><td colspan="3">from 31 to 60</td><td colspan="3">over 61</td><td colspan="3">Male</td><td colspan="3">Female</td></tr><tr><td></td><td>%</td><td colspan="2">95% C.I.</td><td>%</td><td colspan="2">95% C.I.</td><td>%</td><td colspan="2">95% C.I.</td><td>%</td><td colspan=... |
a44a192764e088a9618901af0389794f351579c57e6eebe5ef8b2943f73ab91a.png | complex | <table><tr><td>Variable</td><td colspan="2">Preview</td><td colspan="2">No-Preview</td></tr><tr><td> </td><td>IB</td><td>No-IB</td><td>IB</td><td>No-IB</td></tr><tr><td>Fixation distance (in pixels) from moving coin on experimental trial</td><td>334 (122)</td><td>296 (123)</td><td>398 (122)</td><td>390 (125)</td></tr><... | <table><tr><td>Variable</td><td colspan="2">Preview</td><td colspan="2">No-Preview</td></tr><tr><td></td><td>IB</td><td>No-IB</td><td>IB</td><td>No-IB</td></tr></table> | <table><tr><td>Fixation distance (in pixels) from moving coin on experimental trial</td><td>334 (122)</td><td>296 (123)</td><td>398 (122)</td><td>390 (125)</td></tr><tr><td>Fixation distance (in pixels) from moving coin on free-viewing trial</td><td>339 (224)</td><td>202 (137)</td><td>380 (156)</td><td>307 (143)</td></... |
357524fb764430aef7b868df8f7432263cfd01a971201d200d357a65b392f25a.png | simple | <table><tr><td>Condition</td><td>Stimulus type</td><td>n</td><td>Before RF (ms)</td><td>After RF (ms)</td><td>t</td><td>P</td></tr><tr><td>Genuine EMF</td><td>Rarefaction</td><td>13</td><td>1.67 ± 0.14</td><td>1.66 ± 0.15</td><td>0.34</td><td>0.737</td></tr><tr><td></td><td>Condensation</td><td>13</td><td>1.6... | <table><tr><td>Condition</td><td>Stimulus type</td><td>n</td><td>Before RF (ms)</td><td>After RF (ms)</td><td>t</td><td>P</td></tr><tr><td>Genuine EMF</td><td>Rarefaction</td><td>13</td><td>1.67 ± 0.14</td><td>1.66 ± 0.15</td><td>0.34</td><td>0.737</td></tr><tr><td></td><td>Condensation</td><td>13</td><td>1.69 ± 0.18</... | <table><tr><td>ation</td><td>14</td><td>0.09</td><td>4</td><td>4</td><td>07</td></tr><tr><td>Alternating</td><td>14</td><td>1.74 ± 0.10</td><td>1.76 ± 0.11</td><td>-1.23</td><td>0.239</td></tr></table> |
d1ce1376e459a69408d63a94342138cfa54aa3c3457ff5649907bef7fea261ae.png | simple | <table><tr><td>Size Factor</td><td>Iterations</td><td>Nodes</td><td>Elements</td><td>Max. Elem. Vol. (mm<sup>3</sup>)</td></tr><tr><td>Initial</td><td>--</td><td>2396</td><td>7574</td><td>0.08</td></tr><tr><td>1.15</td><td>17</td><td>1332</td><td>3904</td><td>0.51</td></tr><tr><td>1.25</td><td>21</td><td>777</td><td>22... | <table><tr><td>Size Factor</td><td>Iterations</td></tr><tr><td>Initial</td><td>--</td></tr><tr><td>1.15</td><td>17</td></tr><tr><td>1.25</td><td>21</td></tr><tr><td>1.35</td><td>20</td></tr></table> | <table><tr><td>Nodes</td><td>Elements</td><td>Max. Elem. Vol. (mm3)</td></tr><tr><td>2396</td><td>7574</td><td>0.08</td></tr><tr><td>1332</td><td>3904</td><td>0.51</td></tr><tr><td>777</td><td>2200</td><td>1.49</td></tr><tr><td>612</td><td>1615</td><td>2.97</td></tr></table> |
7211d1bd535fb9c2062f351b71d4ec0fd1764fa68ad3add32be52b63c8d00732.png | simple | <table><tr><td>Characteristics</td><td>Number (%)</td></tr><tr><td>Age range (year)</td><td>6–88</td></tr><tr><td>Mean age (year) (SD)</td><td>42.5 ± 17.53</td></tr><tr><td>Length of stay (day) range</td><td>0–15</td></tr><tr><td>Mean length of stay (day) (SD)</td><td>8.3 ± 5.3</td></tr><tr><td>Le... | <table><tr><td>Characteristics</td><td>Number (%)</td></tr><tr><td>Age range (year)</td><td>6–88</td></tr><tr><td>Mean age (year) (SD)</td><td>42.5 ± 17.53</td></tr><tr><td>Length of stay (day) range</td><td>0–15</td></tr><tr><td>Mean length of stay (day) (SD)</td><td>8.3 ± 5.3</td></tr><tr><td>Length of stay (day)</td... | <table><tr><td>≤1 week</td><td>67 (57.7)</td></tr><tr><td>More than one week</td><td>21 (18.1)</td></tr><tr><td>Sex</td><td></td></tr><tr><td>Male</td><td>63 (54.4)</td></tr><tr><td>Female</td><td>53 (45.6)</td></tr><tr><td>Hospitalization</td><td></td></tr><tr><td>Yes</td><td>87 (75)</td></tr><tr><td>No</td><td>29 (25... |
1800a0d8a09a99b9fa1ad266ef36d5d1ee21a6a0ca3e666e9447bec7e7a36c44.png | complex | <table><tr><td rowspan="2">Parameter</td><td rowspan="2">Unit</td><td colspan="6">Soil sample</td></tr><tr><td>WD1</td><td>WD2</td><td>WD3</td><td>ZR1</td><td>ZR2</td><td>ZR3 </td></tr><tr><td>Particle size </td><td> </td><td>SL</td><td>SL</td><td>SL</td><td>SL</td><td>SL</td><td>SL</td></tr><tr><td>pH</td><td> </td><t... | <table><tr><td rowspan="2">Parameter</td><td rowspan="2">Unit</td><td colspan="6">Soil sample</td></tr><tr><td>WD1</td><td>WD2</td><td>WD3</td><td>ZR1</td><td>ZR2</td><td>ZR3</td></tr><tr><td>Particle size</td><td></td><td>SL</td><td>SL</td><td>SL</td><td>SL</td><td>SL</td><td>SL</td></tr><tr><td>pH</td><td></td><td>8.... | <table><tr><td>ESP</td><td>%</td><td>8.9</td><td>9.2</td><td>2.6</td><td>9.9</td><td>1.8</td><td>3.9</td></tr><tr><td>OM</td><td>%</td><td>2.0</td><td>1.1</td><td>2.1</td><td>1.6</td><td>1.0</td><td>2.1</td></tr><tr><td>CaCO3</td><td>%</td><td>33.1</td><td>32.5</td><td>36.1</td><td>40.6</td><td>61.6</td><td>22.3</td></... |
9c4b9b23334242dbcfb524df13d3e0eab8495b235f70bc56a98f508d86e47d57.png | complex | <table><tr><td rowspan="3">HIV Knowledge and Prevention Practices</td><td colspan="3">Men</td><td colspan="3">Women</td><td>Test for difference by sex<sup>c</sup></td></tr><tr><td colspan="3"><i>n</i> = 755</td><td colspan="3"><i>n</i> = 1369</td><td></td></tr><tr><td>Yes</td><td>No</td><td>Don’t know/not sure</t... | <table><tr><td rowspan="3">HIV Knowledge and Prevention Practices</td><td colspan="3">Men</td><td colspan="3">Women</td><td>Test for difference by sexc</td></tr><tr><td colspan="3">n = 755</td><td colspan="3">n = 1369</td><td></td></tr><tr><td>Yes</td><td>No</td><td>Don’t know/not sure</td><td>Yes</td><td>No</td><td>Do... | <table><tr><td rowspan="3">HIV Knowledge and Prevention Practices</td><td colspan="3">Men</td><td colspan="3">Women</td><td>Test for difference by sexc</td></tr><tr><td colspan="3">n = 755</td><td colspan="3">n = 1369</td><td></td></tr><tr><td>Yes</td><td>No</td><td>Don’t know/not sure</td><td>Yes</td><td>No</td><td>Do... |
f9d0e53fc1c3697b77fdb89b795439470bee437287c96cdc3b0f953257fbd60c.png | simple | <table><tr><td>Doctors</td><td>Organisations/ Designated body</td><td>GMC</td></tr><tr><td>Licensed doctors who are not trainees must:- Have a connection to one organisation (known as a designated body).- Take part in regular appraisal- Collect supporting information for appraisal: 6 types • CPD (annually) •... | <table><tr><td>Doctors</td></tr><tr><td>Licensed doctors who are not trainees must:- Have a connection to one organisation (known as a designated body).- Take part in regular appraisal- Collect supporting information for appraisal: 6 types • CPD (annually) • significant events (annually) • review of complaints and comp... | <table><tr><td>Organisations/ Designated body</td><td>GMC</td></tr><tr><td>Organisations are required by the GMC to provide:- a RO new role, responsible for the revalidation recommendation)- an up to date appraisal system and ensure every licensed doctor has a regular appraisal- a sufficient number of trained appraiser... |
002bfeebe20be2e97fab46b99ce68321afb8972f6d8f131f0c1f5392819d3a23.png | simple | <table><tr><td> </td><td>Small-for-gestational age group (<i>n</i> = 10)</td><td>Appropriate-for-gestational age group (<i>n</i> = 7)</td></tr><tr><td>Age at delivery (years)</td><td>27.3 ± 5.2</td><td>26.4 ± 6.5</td></tr><tr><td>Gestational age at delivery (weeks)</td><td>38.4 ± 1.0</td><td>39.7 ± ... | <table><tr><td></td><td>Small-for-gestational age group (n = 10)</td><td>Appropriate-for-gestational age group (n = 7)</td></tr></table> | <table><tr><td>Age at delivery (years)</td><td>27.3 ± 5.2</td><td>26.4 ± 6.5</td></tr><tr><td>Gestational age at delivery (weeks)</td><td>38.4 ± 1.0</td><td>39.7 ± 0.7</td></tr><tr><td>Birth weight (grams)</td><td>2159 ± 506</td><td>3156 ± 301*</td></tr><tr><td>TGF-β1 levels at 34 weeks (ng/mL)</td><td>32.5 ± 3.2</td><... |
e1e6a11104f08cb81cb18b3b61f25a688630347486a03f83f9b878686752239b.png | simple | <table><tr><td>Indicators</td><td>2006</td><td>2007</td><td>2008</td><td>2009</td><td>2010</td><td>2011</td><td>2012</td></tr><tr><td>Interviewed</td><td>54,369</td><td>54,251</td><td>54,353</td><td>54,367</td><td>54,339</td><td>54,144</td><td>45,448</td></tr><tr><td>Females (%)</td><td>53.9</td><td>53.9</td><td>53.9</... | <table><tr><td>Indicators</td><td>2006</td><td>2007</td><td>2008</td><td>2009</td><td>2010</td><td>2011</td><td>2012</td></tr><tr><td>Interviewed</td><td>54,369</td><td>54,251</td><td>54,353</td><td>54,367</td><td>54,339</td><td>54,144</td><td>45,448</td></tr><tr><td>Females (%)</td><td>53.9</td><td>53.9</td><td>53.9</... | <table><tr><td>0-4 years of schooling (%)</td><td>21.6</td><td>20.4</td><td>19.4</td><td>18.0</td><td>16.8</td><td>17.2</td><td>16.1</td></tr><tr><td>Response rate (%)</td><td>90.9</td><td>92.3</td><td>94.2</td><td>97.0</td><td>97.7</td><td>97.8</td><td>94.1</td></tr></table> |
f0f4582a95cef84b07f442570adc4ebb35829ea87628723507e737496176bf25.png | complex | <table><tr><td>Output variable</td><td>Predictive variables</td><td>R<sup>2</sup></td><td>B(Coef)</td><td>p</td><td>95%CI</td><td>HL<sup>*</sup></td></tr><tr><td rowspan="2">Cardiovascular risk (PDAY)</td><td>Sex</td><td rowspan="2">0.271</td><td>0.090</td><td>< 0.01</td><td>0.044-0.183</td><td rowspan="2">0,939</td... | <table><tr><td>Output variable</td><td>Predictive variables</td><td>R2</td><td>B(Coef)</td><td>p</td><td>95%CI</td><td>HL*</td></tr><tr><td>Cardiovascular risk</td><td>Se</td><td></td><td>0</td><td>< 0.01</td><td>0</td><td>0,939</td></tr></table> | <table><tr><td rowspan="2"> (PDAY)</td><td>x</td><td rowspan="2">0.271</td><td>.090</td><td></td><td>.044-0.183</td></tr><tr><td>Waist circumference</td><td>0.043</td><td>< 0.01</td><td>0.014-0.136</td></tr></table> |
76f67c1340d24d24eee4dfb79ea3284bc6083e819ca6873b75c8188828b09480.png | simple | <table><tr><td>NH<sub>4</sub>NO<sub>3</sub> (g/L)</td><td>Residual sugar (g/L)</td><td>Cell biomass (g/L)</td><td>PMA (g/L)</td><td>Productivity (g/L h)</td><td>Yield (Y<sub>P/X</sub>, g/g)</td><td>Yield (Y<sub>P/S</sub>, g/g)</td></tr><tr><td>0.1</td><td>56.67 ± 0.50</td><td>6.23 ± 0.71</td><td>6.17 ± 0... | <table><tr><td>NH4NO3 (g/L)</td><td>Residual sugar (g/L)</td><td>Cell biomass (g/L)</td><td>PMA (g/L)</td><td>Productivity (g/L h)</td><td>Yield (YP/X, g/g)</td><td>Yield (YP/S, g/g)</td></tr><tr><td>0.1</td><td>56.67 ± 0.50</td><td>6.23 ± 0.71</td><td>6.17 ± 0.29</td><td>0.06 ± 0.003</td><td>1.00 ± 0.137</td><td>0.18 ... | <table><tr><td>NH4NO3 (g/L)</td><td>Residual sugar (g/L)</td><td>Cell biomass (g/L)</td><td>PMA (g/L)</td><td>Productivity (g/L h)</td><td>Yield (YP/X, g/g)</td><td>Yield (YP/S, g/g)</td></tr><tr><td>0.5</td><td>40.77 ± 0.12</td><td>13.09 ± 1.09</td><td>10.86 ± 1.91</td><td>0.09 ± 0.042</td><td>0.85 ± 0.246</td><td>0.2... |
590c198428ddc9f6b180abebae8488ab3281e9295d50be77ef6ca04af200b07c.png | simple | <table><tr><td>Score cutoff</td><td>Sensitivity</td><td>Specificity</td><td>PPV <sup>b</sup></td><td>NPV <sup>b</sup></td><td>LR+</td><td>LR-</td></tr><tr><td>≧1</td><td>0.96</td><td>0.13</td><td>0.37</td><td>0.86</td><td>1.10</td><td>0.31</td></tr><tr><td>≧2</td><td>0.96</td><td>0.18</td><td>0.38</td><td>0... | <table><tr><td>Score cutoff</td><td>Sensitivity</td></tr><tr><td>≧1</td><td>0.96</td></tr><tr><td>≧2</td><td>0.96</td></tr><tr><td>≧3</td><td>0.75</td></tr><tr><td>≧4</td><td>0.63</td></tr><tr><td>5</td><td>0.21</td></tr></table> | <table><tr><td>Specificity</td><td>PPV b</td><td>NPV b</td><td>LR+</td><td>LR-</td></tr><tr><td>0.13</td><td>0.37</td><td>0.86</td><td>1.10</td><td>0.31</td></tr><tr><td>0.18</td><td>0.38</td><td>0.89</td><td>1.16</td><td>0.23</td></tr><tr><td>0.69</td><td>0.56</td><td>0.84</td><td>2.41</td><td>0.36</td></tr><tr><td>0.... |
5a868c1005f03ca9954934b629f91947975c8174df2b65fe92f835129f063d44.png | simple | <table><tr><td> </td><td>Before 14 days</td><td>At/later 14 days</td><td>p-value</td></tr><tr><td>N</td><td>150</td><td>26</td><td> </td></tr><tr><td>Mean age, years (SD)</td><td>51.8 (12.7)</td><td>52.6 (15.5)</td><td>NS</td></tr><tr><td>First transplantation</td><td>138/150 (92.0%)</td><td>24/26 (92.3%)</td><td>NS</t... | <table><tr><td></td><td>Before 14 days</td><td>At/later 14 days</td><td>p-value</td></tr><tr><td>N</td><td>150</td><td>26</td><td></td></tr><tr><td>Mean age, years (SD)</td><td>51.8 (12.7)</td><td>52.6 (15.5)</td><td>NS</td></tr><tr><td>First transplantation</td><td>138/150 (92.0%)</td><td>24/26 (92.3%)</td><td>NS</td>... | <table><tr><td>1-year patient survival</td><td>149 (99.3%)</td><td>25 (96.2%)</td><td>NS</td></tr></table> |
51fb75399d91236187dbbeacbe49c1cbb629716bb8ce2c2ac189dad02c13ed9f.png | complex | <table><tr><td rowspan="2"> </td><td>Without CKD<sup>a</sup></td><td> </td><td> </td><td>With CKD</td><td> </td><td> </td></tr><tr><td>Variables</td><td>BMI 18.5-24.9 (N = 1398)</td><td>BMI 25–29.9 (N = 2314)</td><td>BMI ≥ 30 (N = 1548)</td><td>BMI 18.5-24.9 (N = 379)</td><td>BMI 25–29.9 (N = 418)</td... | <table><tr><td rowspan="2"></td></tr><tr></tr><tr><td>Variables</td></tr><tr><td>No. of person-years</td></tr><tr><td>No. of incidence CVD</td></tr><tr><td>Incidence rate</td></tr><tr><td>(per 10,000 person-years)</td></tr><tr><td>Unadjusted HRs</td></tr><tr><td>Adjusted HRs</td></tr><tr><td>Model 1†</td></tr><tr><td>M... | <table><tr><td>Without CKDa</td><td></td><td></td><td>With CKD</td><td></td><td></td></tr><tr><td colspan="6"></td></tr><tr><td>BMI 18.5-24.9 (N = 1398)</td><td>BMI 25–29.9 (N = 2314)</td><td>BMI ≥ 30 (N = 1548)</td><td>BMI 18.5-24.9 (N = 379)</td><td>BMI 25–29.9 (N = 418)</td><td>BMI ≥ 30 (N = 152)</td></tr><tr><td>12... |
07d16546d641b79c1f44b8f65420e54ada9f9ec52d1b131a716db94538650428.png | complex | <table><tr><td></td><td colspan="2">Skin Prick</td><td colspan="2">sIgE</td><td colspan="2">APT</td><td colspan="2">History</td></tr><tr><td></td><td>A</td><td>B</td><td>A</td><td>B</td><td>A</td><td>B</td><td>A</td><td>B</td></tr><tr><td><i>D. pteronyssinus </i></td><td>59</td><td>56</td><td>56</td><td>56</td><td>34</... | <table><tr><td></td><td colspan="2">Skin Prick</td><td colspan="2">sIgE</td><td colspan="2">APT</td><td colspan="2">History</td></tr><tr><td></td><td>A</td><td>B</td><td>A</td><td>B</td><td>A</td><td>B</td><td>A</td><td>B</td></tr><tr><td>D. pteronyssinus</td><td>59</td><td>56</td><td>56</td><td>56</td><td>34</td><td>3... | <table><tr><td>t dander</td><td></td><td>4</td><td>49</td><td>6</td><td>2</td><td>10</td><td>3</td><td></td></tr><tr><td>Grass pollen</td><td>65</td><td>57</td><td>75</td><td>59</td><td>18</td><td>15</td><td>33</td><td>31</td></tr><tr><td>Birch pollen</td><td>65</td><td>49</td><td>65</td><td>53</td><td>11</td><td>17</t... |
f990f2636d05661b59ca1ad4621da0a6b172f5225f71e35d1fe789e218d572d1.png | simple | <table><tr><td></td><td>ZA group (<i>n</i> = 27)</td><td>Control group (<i>n</i> = 27)</td></tr><tr><td>Age (years), mean (SD)</td><td>60.1 (11.7)</td><td>59.4 (13.3)</td></tr><tr><td>Sex, female:male</td><td>15:12</td><td>14:13</td></tr><tr><td>BMI (kg/m<sup>2</sup>), mean (SD)</td><td>26 (4)</td><td>25 (5)</td></tr><... | <table><tr><td></td><td>ZA group (n = 27)</td><td>Control group (n = 27)</td></tr><tr><td>Age (years), mean (SD)</td><td>60.1 (11.7)</td><td>59.4 (13.3)</td></tr></table> | <table><tr><td></td><td>ZA group (n = 27)</td><td>Control group (n = 27)</td></tr><tr><td>Sex, female:male</td><td>15:12</td><td>14:13</td></tr><tr><td>BMI (kg/m2), mean (SD)</td><td>26 (4)</td><td>25 (5)</td></tr><tr><td>Operation time (minutes), mean (SD)a</td><td>118 (27)</td><td>103 (17)</td></tr><tr><td>Blood loss... |
c3537b0d19e3710915f303adf519ae4b7d99d1d990175791d644654a17c8b249.png | simple | <table><tr><td>S. No</td><td>Water soluble</td><td>Exchangeable</td><td>Carbonate & sulfide</td><td>Reducible fraction</td><td>Oxidisable fraction</td><td>Residual fraction</td><td>Total Cr</td></tr><tr><td>1a</td><td>51.85 ± 0.34</td><td>29.62 ± 0.20</td><td>17.28 ± 0.30</td><td>98.76 ± 0.92</t... | <table><tr><td>S. No</td><td>Water soluble</td><td>Exchangeable</td><td>Carbonate & sulfide</td><td>Reducible fraction</td><td>Oxidisable fraction</td><td>Residual fraction</td><td>Total Cr</td></tr><tr><td>1a</td><td>51.85 ± 0.34</td><td>29.62 ± 0.20</td><td>17.28 ± 0.30</td><td>98.76 ± 0.92</td><td>55.55 ± 0.32</td><... | <table><tr><td>S. No</td><td>Water soluble</td><td>Exchangeable</td><td>Carbonate & sulfide</td><td>Reducible fraction</td><td>Oxidisable fraction</td><td>Residual fraction</td><td>Total Cr</td></tr><tr><td>9c</td><td>287.2 ± 2.10</td><td>12.04 ± 0.10</td><td>66.26 ± 0.63</td><td>93.97 ± 0.53</td><td>33.13 ± 0.04</td><... |
8a1fd4708ffcbe346aa51679a8839c28ff93bb8d53add240323403e25f8d8dbe.png | complex | <table><tr><td>Genus</td><td>Individuals</td><td>Assemblages</td><td>Mean vector (μ)</td><td>Length of mean vector (r)</td><td>Concentration</td><td>Circular variance</td><td>Circular standard deviation</td><td>Rayleigh's Z (<i>P</i>)</td><td>Rao's spacing test (<i>P</i>)</td></tr><tr><td colspan="10">Astroblepida... | <table><tr><td>Genus</td><td>Individuals</td><td>Assemblages</td><td>Mean vector (μ)</td><td>Length of mean vector (r)</td><td>Concentration</td><td>Circular variance</td><td>Circular standard deviation</td><td>Rayleigh's Z (P)</td><td>Rao's spacing test (P)</td></tr><tr><td colspan="10">Astroblepidae</td></tr><tr><td>... | <table><tr><td>Genus</td><td>Individuals</td><td>Assemblages</td><td>Mean vector (μ)</td><td>Length of mean vector (r)</td><td>Concentration</td><td>Circular variance</td><td>Circular standard deviation</td><td>Rayleigh's Z (P)</td><td>Rao's spacing test (P)</td></tr><tr><td>Hypancistrus*</td><td>25</td><td>4</td><td>1... |
a2073fdd9536f481d0e742116295417d8794a567d82b5454fecab901fb761342.png | simple | <table><tr><td></td><td>Sodium ibuprofen(geometric means)</td><td>Ibuprofen/ poloxamer(geometric means)</td><td>Standard ibuprofen(geometric means)</td><td>Ratio (%)sodium ibuprofen/ standard ibuprofen</td><td>90% confidence interval</td><td>Ratio (%)ibuprofen/ poloxamer/ standard ibuprofen</td><td>90% confidence inter... | <table><tr><td></td><td>Sodium ibuprofen(geometric means)</td><td>Ibuprofen/ poloxamer(geometric means)</td><td>Standard ibuprofen(geometric means)</td><td>Ratio (%)sodium ibuprofen/ standard ibuprofen</td><td>90% confidence interval</td><td>Ratio (%)ibuprofen/ poloxamer/ standard ibuprofen</td><td>90% confidence inter... | <table><tr><td></td><td>Sodium ibuprofen(geometric means)</td><td>Ibuprofen/ poloxamer(geometric means)</td><td>Standard ibuprofen(geometric means)</td><td>Ratio (%)sodium ibuprofen/ standard ibuprofen</td><td>90% confidence interval</td><td>Ratio (%)ibuprofen/ poloxamer/ standard ibuprofen</td><td>90% confidence inter... |
b0615727e9559f8873551394ca4eecba28cb8828e365043294075b9f77a39913.png | simple | <table><tr><td>Activity</td><td>A1</td><td>A2</td><td>A3</td><td>A4</td><td>A5</td><td>A6</td><td>A7</td></tr><tr><td>A1</td><td>30</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td></tr><tr><td>A2</td><td>1</td><td>29</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td></tr><tr><td>A3</td><td>0</td><td... | <table><tr><td>Activity</td><td>A1</td><td>A2</td><td>A3</td><td>A4</td><td>A5</td><td>A6</td><td>A7</td></tr><tr><td>A1</td><td>30</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td></tr><tr><td>A2</td><td>1</td><td>29</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td></tr></table> | <table><tr><td>Activity</td><td>A1</td><td>A2</td><td>A3</td><td>A4</td><td>A5</td><td>A6</td><td>A7</td></tr><tr><td>A3</td><td>0</td><td>0</td><td>30</td><td>0</td><td>0</td><td>0</td><td>0</td></tr><tr><td>A4</td><td>0</td><td>0</td><td>0</td><td>30</td><td>0</td><td>0</td><td>0</td></tr><tr><td>A5</td><td>0</td><td... |
39a0877f2546bfef74b380db9c01f0332fb67e3875204bc78fbe4e4bfaf71adc.png | simple | <table><tr><td>Diagnosis</td><td>anti-MAP1Abs+</td><td>anti-MAP1Abs−</td><td>anti-MAP2Abs+</td><td>anti-MAP2Abs−</td><td>IS900+</td><td>IS900−</td></tr><tr><td>CD</td><td>13 (46%)</td><td>15 (54%)</td><td>11 (39%)</td><td>17 (61%)</td><td>18 (64%)</td><td>10 (36%)</td></tr><tr><td>UC</td><td>1 (3%)</t... | <table><tr><td>Diagnosis</td><td>anti-MAP1Abs+</td><td>anti-MAP1Abs−</td><td>anti-MAP2Abs+</td><td>anti-MAP2Abs−</td><td>IS900+</td></tr><tr><td>CD</td><td>13 (46%)</td><td>15 (54%)</td><td>11 (39%)</td><td>17 (61%)</td><td>18 (64%)</td></tr><tr><td>UC</td><td>1 (3%)</td><td>29 (97%)</td><td>5 (16.7%)</td><td>25 (83.3%... | <table><tr><td>IS900−</td></tr><tr><td>10 (36%)</td></tr><tr><td>20 (67%)</td></tr><tr><td>55 (90.3%)</td></tr></table> |
c242ac653653a214e05a7e9f820b84091520536388803879aaaba4d691570ed4.png | simple | <table><tr><td>RBM, um<sup>b</sup></td><td>RBM, um<sup>c</sup></td><td>ASM% large AW</td><td>ASM% small AW</td><td>T-cell<sup>a</sup></td><td>B- cell</td><td>MF</td><td>Mast</td><td>Eos</td><td>CD15</td><td>PDC</td><td>Mucus large AW (0–3)</td><td>Mucus small AW (0–3)</td></tr><tr><td>Cases</td><td></td><td... | <table><tr><td>RBM, umb</td><td>RBM, umc</td><td>ASM% large AW</td><td>ASM% small AW</td><td>T-cella</td><td>B- cell</td><td>MF</td><td>Mast</td><td>Eos</td><td>CD15</td><td>PDC</td><td>Mucus large AW (0–3)</td><td>Mucus small AW (0–3)</td></tr><tr><td>Cases</td><td></td><td></td><td></td><td></td><td></td><td></td><td... | <table><tr><td>6,4</td><td>4,7</td><td>14</td><td>18</td><td>421</td><td>443</td><td>1133</td><td>153</td><td>320</td><td>107</td><td>20</td><td>3</td><td>1</td></tr><tr><td>4,8</td><td>5</td><td>10</td><td>NA</td><td>166</td><td>51</td><td>320</td><td>151</td><td>700</td><td>140</td><td>14</td><td>3</td><td>1</td></tr... |
459c55c9ee23139c3f65bf8d3855b1d36d215523cdac479f191173d0b897806f.png | simple | <table><tr><td>Mouse</td><td>Number</td><td>Rate</td><td>Theoretical rate</td><td>Theoretical value</td><td>χ<sup>2</sup> test</td></tr><tr><td>Total</td><td>657</td><td>—</td><td>—</td><td>—</td><td>—</td></tr><tr><td>WT</td><td>153</td><td>1</td><td>1</td><td>164.25</td><td></td></tr><tr>... | <table><tr><td>Mouse</td><td>Number</td><td>Rate</td><td>Theoretical rate</td></tr><tr><td>Total</td><td>657</td><td>—</td><td>—</td></tr><tr><td>WT</td><td>153</td><td>1</td><td>1</td></tr><tr><td>Heterozygous</td><td>330</td><td>2.06</td><td>2</td></tr><tr><td>KO</td><td>174</td><td>0.98</td><td>1</td></tr></table> | <table><tr><td>Theoretical value</td><td>χ2 test</td></tr><tr><td>—</td><td>—</td></tr><tr><td>164.25</td><td></td></tr><tr><td>328.5</td><td></td></tr><tr><td>164.25</td><td>0.50759</td></tr></table> |
fd48ae850a9daa8e2fb71f51c466addc6ba954b32064e8f6aeace63beaa04451.png | simple | <table><tr><td>Density Measure</td><td>Confirmed Spn Cases<sup>a</sup></td><td>RSV+ Cases<sup>b</sup></td><td>Controls Targeted for CRP Testing<sup>c</sup></td><td>Confirmed Non- Spn Bacterial Cases<sup>d</sup></td></tr><tr><td>NP/OP PCR Spn density</td><td>(n = 36)</td><td>(n = 858)</td><td>(n = 597)</td><td>(n = 79)<... | <table><tr><td>Density Measure</td><td>Confirmed Spn Casesa</td><td>RSV+ Casesb</td><td>Controls Targeted for CRP Testingc</td><td>Confirmed Non- Spn Bacterial Casesd</td></tr><tr><td>NP/OP PCR Spn density</td><td>(n = 36)</td><td>(n = 858)</td><td>(n = 597)</td><td>(n = 79)</td></tr><tr><td>NP/OP PCR density > 106.9 c... | <table><tr><td>Density >102.2 copies/mLe alone</td><td>18 (51.4)</td><td>19 (2.2)</td><td>119 (19.9)</td><td>4 (5.1)</td></tr><tr><td>+ CRP ≥40 mg/L</td><td>17 (48.6)</td><td>3 (0.4)</td><td>5 (0.8)</td><td>3 (3.9)</td></tr><tr><td>+ CRP ≥100 mg/L</td><td>16 (45.7)</td><td>1 (0.1)</td><td>1 (0.2)</td><td>1 (1.3)</td></... |
06f4f7409a158308b1e5fa287ad57743b97ad87fe3d6cf4c4f3dbc6f63800d46.png | simple | <table><tr><td></td><td>Number of patients with positive test result(<i>n</i> = 30)</td></tr><tr><td>Spices</td><td>27</td></tr><tr><td>Seeds and nuts</td><td>24</td></tr><tr><td>Seafood</td><td>24</td></tr><tr><td>Starch</td><td>22</td></tr><tr><td>Food additives</td><td>21</td></tr><tr><td>Vegetables</td><td>21</td><... | <table><tr><td></td><td>Number of patients with positive test result(n = 30)</td></tr><tr><td>Spices</td><td>27</td></tr><tr><td>Seeds and nuts</td><td>24</td></tr><tr><td>Seafood</td><td>24</td></tr><tr><td>Starch</td><td>22</td></tr><tr><td>Food additives</td><td>21</td></tr><tr><td>Vegetables</td><td>21</td></tr><tr... | <table><tr><td>Infusions</td><td>3</td></tr><tr><td>Salads</td><td>10</td></tr><tr><td>Mushrooms</td><td>9</td></tr><tr><td>Yeast</td><td>5</td></tr><tr><td>Meat</td><td>5</td></tr></table> |
1743476203e554fb14dd9f869eba123f005cab2c9da0479c4a50ae4f58373f81.png | simple | <table><tr><td></td><td>n = 88</td></tr><tr><td>Patient age (years)Mean ± SD</td><td>36 ± 9.3</td></tr><tr><td>Sex (female/male)n (%)</td><td>60/28 (68.19/31.81 %)</td></tr><tr><td>BMI (kg/m<sup>2</sup>)Mean ± SD</td><td>48.65 ± 7.71</td></tr></table> | <table><tr><td></td><td>n = 88</td></tr></table> | <table><tr><td>Patient age (years)Mean ± SD</td><td>36 ± 9.3</td></tr><tr><td>Sex (female/male)n (%)</td><td>60/28 (68.19/31.81 %)</td></tr><tr><td>BMI (kg/m2)Mean ± SD</td><td>48.65 ± 7.71</td></tr></table> |
55a84988e855aed8c052e983318eb0fca24e43f1512e12202e5a41f9fa24a4b7.png | simple | <table><tr><td></td><td>Non-interacting</td><td>Interacting</td></tr><tr><td>unconstrained</td><td>Z-score = 8.17, AUC = 93.48%</td><td>Z-score = 7.09, AUC = 91.06%</td></tr><tr><td>constrained</td><td>Z-score = 4.32, AUC = 87.01%</td><td>Z-score = 6.94, AUC = 90.07%</td></tr></table> | <table><tr><td></td><td>Non-int</td><td>Interact</td></tr></table> | <table><tr><td></td><td>eracting</td><td>ing</td></tr><tr><td>unconstrained</td><td>Z-score = 8.17, AUC = 93.48%</td><td>Z-score = 7.09, AUC = 91.06%</td></tr><tr><td>constrained</td><td>Z-score = 4.32, AUC = 87.01%</td><td>Z-score = 6.94, AUC = 90.07%</td></tr></table> |
04385580fe5a9b33fb7e9d37bd7ae8599ff1ac83ac639ecdcbeb20a7ec629a51.png | simple | <table><tr><td></td><td>Endocan (pg/ml)</td><td>Osteoprotegerin (pmol/l)</td></tr><tr><td>Baseline</td><td>146 ± 110</td><td>4,4 ± 2,4</td></tr><tr><td>2 months</td><td>168 ± 133</td><td>4,5 ± 2,7</td></tr><tr><td>4 months</td><td>168 ± 134</td><td>4,6 ± 2,3</td></tr><tr><td>6 months</td><... | <table><tr><td></td><td>Endocan (pg/ml)</td><td>Osteoprotegerin (pmol/l)</td></tr><tr><td>Baseline</td><td>146 ± 110</td><td>4,4 ± 2,4</td></tr><tr><td>2 months</td><td>168 ± 133</td><td>4,5 ± 2,7</td></tr><tr><td>4 months</td><td>168 ± 134</td><td>4,6 ± 2,3</td></tr><tr><td>6 months</td><td>179 ± 224</td><td>4,4 ± 2,0... | <table><tr><td></td><td>Endocan (pg/ml)</td><td>Osteoprotegerin (pmol/l)</td></tr><tr><td>8 months</td><td>196 ± 238</td><td>4,3 ± 2,1</td></tr><tr><td>Paired sample t-test</td><td>p-value = 0,036</td><td>p-value = 0,668</td></tr><tr><td>Friedman test</td><td>Chi-Square: 12,696Asymp. Significance: 0,013</td><td>Chi-Squ... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.